A New Estimating Equation Based Approach for Secondary Trait Analyses in Genetic Case-control Studies by Song, Xiaoyu
A New Estimating Equation Based Approach for
Secondary Trait Analyses in Genetic
Case-control Studies
Xiaoyu Song
A thesis submitted in partial fulfillment for the
degree of Doctor of Public Health
in the
Mailman School of Public Health
Columbia University






A New Estimating Equation Based Approach for Secondary Trait
Analyses in Genetic Case-control Studies
Xiaoyu Song
Background/Aims: Case-control designs are commonly employed in genetic as-
sociation studies. In addition to the primary trait of interest, data on additional
secondary traits, related to the primary trait, are often collected. Traditional as-
sociation analyses between genetic variants and secondary traits can be biased in
such cases, and several methods have been proposed to address this issue, including
the inverse-probability-of-sampling-weighted (IPW) approach and semi-parametric
maximum likelihood (SPML) approach.
Methods: Here, we propose a set of new estimating equation based approach that
combines observed and counter-factual outcomes to provide unbiased estimation
of genetic associations with secondary traits. We extend the estimating equation
framework to both generalized linear models (GLM) and non-parametric regres-
sions, and compare it with the existing approaches.
Results: We demonstrate analytically and numerically that our proposed approach
provides robust and fairly efficient unbiased estimation in all simulations we con-
sider. Unlike existing methods, it is less sensitive to the sampling scheme and un-
derlying disease model specification. In addition, we illustrate our new approach
using two real data examples. The first one is to analyze the binary secondary trait
diabetes under GLM framework using a stroke case-control study. The second one is
to analyze the continuous secondary trait serum IgE levels under linear and quantile
regression models using an asthma case-control study.
Conclusion: The proposed new estimating equation approach is able to accommo-
date a wide range of regressions, and it outperforms the existing approaches in some
scenarios we consider.
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No two humans are genetically identical. This is true even for monozygotic twins who
develop from the same zygote. The differences between individuals come from a variety
of aspects, such as single nucleotide polymorphisms (SNPs), structural variation and epi-
genetics, to name a few. These genetic variations can affect how humans develop diseases
and respond to pathogens, chemicals, drugs, vaccines and other agents. Understanding
the variations in human genetics is important to detect, prevent and treat the diseases that
are caused by genetic abnormalities and mutations. It is also especially critical for the
development of personalized medicine that tailors health care for each individual patient.
One of the most commonly occurred variations throughout a person’s DNA is the SNP
that each person has on average roughly 10 millions SNPs across whole genome. A SNP is
a single nucleotide (A, T, C or G) mutation at a specific locus of the DNA sequence between
paired chromosomes or members of a biological species. Since humans are diploid organ-
isms, the SNPs have two alleles (where the rare allele frequency is >1%) at each genetic
locus, with one allele inherited from each parent. A single SNP may cause a Mendelian
disease that follows a simple pattern of inheritance known as the Mendel’s laws [Mendel,
1865]. Examples include sickle-cell anemia, Tay-Sachs disease, cystic fibrosis and xero-
derma pigmentosa. Most of the Mendelian diseases have been well studied in the litera-
ture and the remaining challenges for current studies are the complex diseases, in which
the SNPs do not usually function individually, but rather work in coordination with other
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SNPs and the environment factors to manifest a disease condition.
An early statistical method to identify disease genes is linkage analysis. Linkage anal-
ysis uses marker data on individuals in families/pedigrees, and studies patterns of co-
inheritance of the markers and the diseases throughout the pedigree. Although linkage
analysis has successfully explained a lot of the Mendelian diseases, such as Huntington’s
disease and cystic fibrosis, it has been less successful for complex traits. One major reason
is that complex diseases often have a large number of SNPs with small or medium effect
sizes, and thus researchers need to collect a large number of families with several affected
generations. If the disease is rare or having late-onset with a high mortality, finding fami-
lies with more than one affected generation will be unpractical. Therefore, linkage studies
are less helpful for complex traits, where multiple genes work together with small effect
size in disease causation.
Unlike linkage studies, Genome-wide association studies (GWAS) allow researchers to
identify the associations between the genetic markers and the complex diseases using unre-
lated individuals. GWAS first proposed by Risch et al. [1996] genotype each subject a dense
set of pre-determined SNPs across the genome, and test for the disease-marker association
at all SNPs. To carry out a GWAS, researchers use two groups of participants: people with
the disease of interest and similar people without the disease. Each person gives a blood
or buccal swab sample of DNA, from which millions of genetic variants are genotyped. If
one type of the variant (one allele) is more or less frequent in people with the disease than
other, then the SNP is said to be "associated" with the disease. The associated SNPs serve as
powerful pointers to the region of the human genome where the disease-causing problem
resides. However, the associated SNPs themselves may not directly cause the disease. They
may just be "tagging along" with the actual causal variants. Researchers often need to take
additional steps to identify the exact genetic change involved in the disease after GWAS.
For example, researchers could sequence DNA base pairs in that particular region of the
genome and conduct additional analysis.
GWAS have successful identified many genetic variations that contribute to a num-
ber of diseases [Visscher et al., 2012], such as type 2 diabetes, Parkinson’s disease, heart
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disorders, obesity, Crohn’s disease and prostate cancer. For example, in 2005, three inde-
pendent studies [Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005] found that
age-related macular degeneration, a common form of blindness, is associated with vari-
ation in the gene for complement factor H that regulates inflammation. Few previously
thought that inflammation might contribute significantly to this type of blindness.
GWAS often use case-control design, and it offers tremendous savings in time and ex-
pense compared with a prospective design. Even so, case-control design remains costly,
and therefore GWAS often collect rich information on additional traits to further improve
the efficiency. The additional traits are mostly important factors associated with the pri-
mary diseases, including biomarkers, characterizations of the disease and anthropometric
parameters. For example, in a chronic obstructive pulmonary disease study [Regan et al.,
2010], the researchers also collected additional respiratory diseases such as asthma, em-
physema and bronchitis.
In addition to the primary analysis, which focuses the association between the SNPs
and case-control status, researchers are also interested in taking full advantage of the ex-
isting data and analyzing genetic associations with the additional traits. The analysis of
the association between the SNPs and additional traits using existing case-control data is
known as "secondary analysis" in the literature. The secondary analysis enables us to inves-
tigate the association between the common variants and secondary traits. Some of them
help discovering the genetic pathways of the primary diseases, while others extend to dif-
ferent interest areas. For example, in Lettre et al. [2008], researchers analyzed height as
the secondary trait using six GWA case-control studies focusing on diabetes, cardiovascular
diseases and cancers. They identified ten SNPs and two previously reported SNPs strongly
associated with height. These 12 SNPs together accounted for approximately 2% of the
population variation in height, and encompassed both strong biological candidates and
unexpected genes. They also highlighted several pathways (let-7 targets, chromatin re-
modeling proteins and Hedgehog signaling) as important regulators of human stature. No
prior GWAS focusing on height has the power to detect these associations, and it showed
the great value of secondary analysis in genetic studies.
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Although conducting the secondary analysis is appealing, it is not straightforward to
obtain an unbiased estimation of the association. In a simple case-control design, the
cases are oversampled to improve the efficiency, and therefore the selected subjects are
no longer representative of the general population. In particular, the subjects are ascer-
tained by combining two randomly selected groups, the group of individuals with specified
primary disease and the group without. When secondary traits are positively associated
with the case-control status, subjects with the large secondary trait values are also over-
sampled; when negatively associated, subjects with the large secondary trait values are
undersampled. As a result, the SNP-secondary trait association in the cases may differ from
the controls. Ignoring the data structure and analyzing the SNP-secondary trait association
using this case-control sample directly would lead to substantive biases. This statistical
problem is further illustrated in the motivating examples in Section 1.1.
The existing methods can be broadly divided as three groups. First, one can use tra-
ditional methods in terms of direct regressions. The analysis can be done among case
sample only, control sample only, combined case-control sample, or combined case-control
sample adjusting the case-control status as a covariate. None of these traditional meth-
ods could estimate the association in the general population consistently. Second, one can
correct the bias by using weights inverse to the probability of selection. This weighted
approach has been long proposed and widely used in survey methods for its simplicity, but
there are concerns over its efficiency. Third, one can explicitly account for the sampling
scheme by modeling the retrospective likelihood function conditioning on the case-control
status. A number of the articles based on the likelihood idea is available in the literature,
and the semi-parametric maximum likelihood (SPML) approach proposed by Lin and Zeng
[2009] is the most recognized for its large improvement in estimating efficiency. However,
the method heavily relies on certain assumption on disease prevalence and is not robust
against mis-specifications that are common in the GWAS studies. In addition, it introduces
profile likelihood function in its estimation process to get rid of the high-dimensional nui-
sance parameters, which is computational intensive.
While GWAS mainly use parametric regressions at this stage for its simplicity, it is desir-
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able to introduce non-parametric regressions to this field. In particular, we are interested
to apply quantile regression [Koenker and Bassett Jr, 1978] as a way to systematically ex-
amine how the SNPs influence the location, scale, and shape of the entire trait distribution.
Quantile regression allows the association between the risk factors and outcomes differ
in different quantiles of the distribution, and therefore is especially useful when the risk
factors are associated with the variances or the extreme values of the outcome. Quantile
regression as well as other non-parametric regressions does not have parametric likelihood
functions, and therefore could be applied with the likelihood based approaches such as
SPML for the secondary analysis.
1.1 Motivating examples
In this section, we describe two real GWAS that motivate our research. One comes from
the Risk Assessment of Cerebrovascular Events Study and the other is from the New York
University Bellevue Asthma Registry.
1.1.1 Risk Assessment of Cerebrovascular Events (RACE) Study
Our first motivating example is a case-control GWAS, Risk Assessment of Cerebrovascular
Events (RACE) Study [Cornelis et al., 2010], from dbGap as part of the Gene Environment
Association Studies initiative funded by the trans-NIH Genes, Environment, and Health
Initiative. This study included 1,220 cases with young onset stroke (stroke before age 60
years) in Pakistan and 1,273 controls from Pakistan Risk of Myocardial Infarction Study.
For each study subject, the study also collects covariate information, including age, gender,
ethnicity, diabetes, cardiovascular disease, myocardial infarction and tobacco usage. The
study genotyped 657,366 genetic variants in the whole genome, including SNPs rs6712932
and rs1990760 that we are interested to investigate for their associations with diabetes.
Two previous studies have identified that SNPs rs6712932 and rs1990760 are associ-
ated with diabetes in white ethnicity European descents. In details, SNP rs6712932-G is
reported to be a protective factor for type-2 diabetes with odds ratio (OR)=0.66 (CI: 0.54
5
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- 0.79) [Salonen et al., 2007] in all white from eastern Finland, Israel, Germany and Eng-
land, and SNP rs1990760-G is reported to be a protective factor for type-1 diabetes with
OR=0.85 (CI: 0.81 - 0.90) [Todd et al., 2007] in self-reported white ethnicity in Great
Britain. It is desirable to verify the association between the pre-reported SNPs and diabetes
in different populations, as it would answer whether the associations are due to hetero-
geneity of the populations or disease mechanisms. We would like to re-investigate the
associations in Pakistan population using the existing stroke case-control data.
Both types of diabetes are known to be risk factors for stroke [Peters et al., 2014;
Sundquist and Li, 2006]. In this dataset, we only have information on whether a sub-
ject has diabetes without further specification on the type of diabetes. Applying simple
logistic regression to the data, we estimate the OR for having young onset stroke asso-
ciated with diabetes is 3.18 (p-value< 0.0001). In addition, both SNPs are associated
with primary disease (young onset stroke) with marginal per-minor-allele OR as 1.14 (p-
value=0.024) and 0.87 (p-value=0.015), respectively. After adjusting for secondary trait
(diabetes), the associations between these SNPs and stroke remain significant (rs6712932:
OR=1.16; p- value=0.017. rs1990760: OR=0.84; p-value=0.003). This is a situation
where the commonly-used estimation methods may provide biased estimation for the as-
sociation between these two SNPs and diabetes. We could observe from Table 1.1 that the
estimates from cases and controls are different. Although we are unable to observe the
true coefficient in the population, we would expect it is closer to the ones among controls
than the ones among cases, since the most of the subjects in the population are healthy
people. Combining the case-control samples and regressing with or without adjusting for





Est βˆ1 OR SE p-value Est βˆ1 OR SE p-value
Case -0.100 0.90 0.092 0.2800 -0.112 0.89 0.088 0.2024
Control -0.125 0.88 0.132 0.3441 -0.247 0.78 0.118 0.0368
CC -0.060 0.94 0.074 0.4166 -0.126 0.88 0.068 0.0648
Adj CC -0.108 0.90 0.076 0.1530 -0.159 0.85 0.071 0.0246
Table 1.1: The association between SNPs and diabetes in a young onset stroke case-control
sample. "Case" stands for logistic regression among case sample only. "Control" stands for
logistic regression among contol sample only. "CC" stands for unadjusted logistic regression
using both case and control samples. "Adj CC" stands for logistic regression using both case
and control samples adjusting for primary disease status.
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1.1.2 New York University Bellevue Asthma Study
Another motivating example is an association study of the Thymic stromal lymphopoi-
etin (TSLP) gene and asthma from the New York University Bellevue Asthma Registry
(NYUBAR) [Liu et al., 2011]. Asthma is a common chronic inflammatory disease of the
airways characterized by variable and recurring symptoms, reversible airflow obstruction
and bronchospasm. Asthma is thought to be caused by a combination of genetic and en-
vironmental factors and is usually diagnosed based on the pattern of symptoms, response
to therapy over time and spirometry. TSLP gene, viewed as a "master switch" of allergic
inflammation at the epithelial cell and dendritic cell interface, is upregulated in asthma.
In their primary analysis, ten tag-SNPs in the TSLP gene were analyzed for association
with asthma using 387 clinically diagnosed asthmatic cases and 212 healthy controls. One
SNP (rs1898671) showed nominally significant association with asthma (OR = 1.50; 95%
CI: 1.09 - 2.05, p = 0.01) after adjusting for age, BMI, income, education and population
stratification.
In this study, we are interested to understand the mechanical pathways of TSLP gene
in affecting the occurrence of asthma. Asthma is almost surely to have allergic basis that it
is very likely to be associated with some type of Immunoglobulin E (IgE) related reaction.
The IgE is a class of antibody that mediates the immune responses in the pathogenesis
of allergic asthma [Burrows et al., 1989]. It binds to allergens and triggers the release
of substances from mast cells that can cause inflammation. In addition to asthma, IgE is
also associated with other allergic diseases, such as allergic rhinitis, peanut allergy, latex
sensitivity, atopic dermatitis, chronic urticaria and allergic bronchopulmonary aspergillosis
[Morjaria and Polosa, 2009]. To further understand the genetic basis of asthma, we would
like to investigate the association between TSLP gene with serum IgE level to uncover
the mediation pathways. It is also helpful to understand the impact of TLSP gene on
other allergic diseases. Figure 1.1 shows the distribution of log serum IgE levels by case-
control status. According to the figure, the log serum IgE levels are approximately normally
distributed among cases and controls, and therefore we can apply least square regression
to analyze the mean genetic association with serum IgE levels. In addition, since high not
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the average serum IgE level is an indicator of allergic diseases, we also want to consider
quantile regression for the genetic association with upper quantiles of IgE in the analysis.
Based on Figure 1.1, asthma is associated with serum IgE levels that cases are more
likely to have high serum IgE levels than healthy controls. This association is clinical and
statistical significant that on average the OR of having asthma with one unit increase in
log serum IgE level is 1.41 (p-value<0.0001). When the secondary trait (serum IgE level)
is associated with primary disease (asthma), the direct analysis using the case-control data
may be biased due to its oversampled cases from the population. Table 1.2 illustrates this
problem by summarizing the association between the ten-tag SNPs in TSLP gene and serum
IgE level separately in cases and controls. For example, we observe the genetic associations
of SNP rs10035870 with log IgE level among cases and controls are very different. Combin-
ing cases and controls with an arbitrary proportion invoke substantive biases. Therefore,
there is a need to utilize novel statistical methods to adjust for the biases, and this novel
method should be able to facilitate quantile regression that does not based on likelihood
functions in the analysis.
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Mean τ= 0.5 τ= 0.75 τ= 0.85
SNPs Sample Est P-val Est P-val Est P-val Est P-val
rs2289276 Case 0.0 0.913 0.0 0.760 0.1 0.472 0.1 0.756
Control 0.0 0.866 0.1 0.505 0.2 0.318 -0.2 0.472
rs1898671 Case -0.2 0.052 -0.2 0.182 -0.2 0.085 -0.2 0.187
Control -0.2 0.219 -0.5 0.065 0.0 0.982 -0.2 0.363
rs11466741 Case -0.1 0.557 0.0 0.764 0.1 0.500 0.0 0.942
Control 0.2 0.212 0.3 0.088 0.4 0.068 0.2 0.322
rs11466743 Case 0.3 0.473 0.0 0.979 0.1 0.841 0.7 0.646
Control -0.5 0.275 0.0 0.904 -0.8 0.064 -1.0 0.003
rs2289277 Case 0.0 0.789 -0.1 0.525 0.1 0.387 0.1 0.507
Control 0.1 0.515 0.1 0.638 0.3 0.105 0.2 0.254
rs2289278 Case 0.3 0.107 0.2 0.490 0.4 0.066 0.2 0.197
Control -0.3 0.294 -0.2 0.470 -0.5 0.275 -0.4 0.444
rs11241090 Case 0.4 0.125 0.4 0.107 0.1 0.779 0.6 0.339
Control 0.3 0.355 0.3 0.416 -0.1 0.842 0.6 0.489
rs10035870 Case -0.1 0.579 0.0 0.987 -0.1 0.657 -0.1 0.668
Control 0.9 0.011 0.9 0.207 0.9 0.000 0.5 0.130
rs11466749 Case 0.2 0.414 -0.1 0.777 0.4 0.223 0.6 0.079
Control 0.0 0.958 -0.1 0.760 0.1 0.827 0.3 0.478
rs11466750 Case 0.2 0.132 0.1 0.541 0.4 0.114 0.6 0.040
Control 0.0 0.818 -0.1 0.695 -0.2 0.625 0.2 0.718
Table 1.2: The association of ten-tag TSLP SNPs and log serum IgE levels in an asthmatic
case-control sample. "Mean" stands for linear regression. "τ" stands for quantile regression
at the τth quantile. "Case" stands for regressions among case sample only. "Control" stands


















In summary, the aforementioned situations have two problems. First, although an extensive
literature have been found on the secondary analysis, there is no approach that is robust to
most of the situations in genetic studies and fairly efficient in identifying the SNPs. Second,
when the secondary traits are continuous, the researchers mainly transform the outcome
to approximately normal distribution and use linear regressions. It ignores the potential
non-linear associations and the associations in other quantities than means.
To address the aforementioned questions, we proposed a new estimating equation
based approach for the analysis of secondary traits in the genetic case-control studies.
Our contributions are two-fold. First, the proposed approach balances the robustness and
efficiency for the secondary analysis. In particular, it has very similar point estimates to the
most robust approach in the literature with smaller standard errors. Second, we generalize
the secondary analysis to the quantile regression, which has great potentials to deepen and
expand the existing knowledge on traditional secondary analysis, and therefore discover
additional candidate SNPs for the complex diseases.
1.3 Structure of this dissertation
The rest of the thesis is organized as follows. In Chapter 2, we first review the existing
approaches for the secondary analysis in genetic case-control studies. It includes discussing
the conditions that traditional methods are able to work, and describing two most popular
novel methods. One is widely used for its robustness, and the other is for its efficiency. In
Chapter 3, we proposed a new estimating equation based approach that provides a general
framework for a wide range of regressions in secondary analysis. An estimation algorithm
for the model parameters is described. The bootstrap method for confidence interval and
hypothesis tests is proposed. In Chapter 4, a series of simulation studies is conducted
to evaluate the performance of the proposed estimation equations in generalized linear
models (GLM) and quantile regression in finite sample sizes. Its performance is compared
with proper existing methods. The Type I error and the model robustness under mis-
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specification of proposed approach is investigated. In Chapter 5, we applied the proposed
estimating equations with existing approaches to the Risk Assessment of Cerebrovascular
Events Study and the New York University Bellevue Asthma Study mentioned earlier. In
Chapter 6, we summarize the important findings in previous chapters and discuss some
future directions of the study.
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Review of secondary analysis in genetic
case-control studies
The secondary analysis of the genetic case-control studies is an important topic which
has received considerable attention in recent years. The existing methods can be broadly
divided as three groups.
First, one can use traditional methods in terms of standard regressions to analyze the
marker-secondary trait associations. The analysis can be done among cases only, controls
only, entire sample ignoring the case-control status, entire sample using case-control status
as a covariate. None of these traditional methods is able to provide unbiased estimation
of marker-secondary trait associations, because cases and controls are selected at different
rates from their respective subpopulations. The case-control sample does not constitute a
random sample of the general population. As a result, the population association between
a SNP and a secondary trait can be distorted in the case-control sample.
Second, one can correct the bias using weighting schemes originally developed from
sampling schemes [Jiang et al., 2006; Monsees et al., 2009; Richardson et al., 2007; Scott
and Wild, 2002]. The inverse-probability-of-sampling-weighted (IPW) regression, also
know as survey-weighted approach, uses weights inversely proportional to the sampling
fractions to the analysis of the secondary traits. This approach provides robust estima-
tion for the marker-secondary trait associations but lacks of the efficiency. Technically, this
14
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approach requires knowledge of the case-control sampling fractions, so it is proposed in
a case-control study nested within a big cohort study. However, in reality, the sampling
scheme is often not clear, and researchers sometimes use the disease prevalence as an
approximation of the sampling scheme.
Third, one can explicitly account for the case-control sampling scheme via maximizing
the retrospective likelihood function conditioning on the sampling scheme [He et al., 2011;
Jiang et al., 2006; Lee et al., 1997; Lin and Zeng, 2009; Scott and Wild, 2001]. The
semi-parametric maximum likelihood (SPML) method proposed by Lin and Zeng [2009]
is the most widely recognized approach using this idea. This method made linear logit
assumption for disease probability relating secondary trait and SNPs, and estimated the
coefficients by maximizing the retrospective likelihood function conditionally on sampling
scheme. This approach largely improves the efficiency of the estimations from IPW, but
when the model assumptions are violated, the resulting estimates could be biased. For this
paper, we mainly review for the SPML approach on behalf of the retrospective likelihood
based methods in the following section.
Other methods based on similar idea of likelihood functions are not as widely applied
in the data analysis as SPML method for different reasons. For example, the bias correction
method [Wang and Shete, 2011, 2012] only deals with binary secondary traits and is
unable to adjust for covarites. The adaptive weighted approach [Li and Gail, 2012] has
difficulties to deal with additive genetic models. Therefore,
In addition to the SPML approach we will review later, there are other approaches
available in the literature based retrospective likelihood functions. They are not as widely
applied in the data analysis as SPML method for different reasons. For example, Li and
Gail [2012] proposed a adaptive weighted approach to weighted sum two estimates to
improve the robustness of the SPML approach. The first estimate is from SPML method,
and the second one follows the same structure of SPML approach but revises P(D|X ,Y )
model to add the X − Y interaction. It is designed to put more weight on SPML estimators
when there is no interaction between X and Y in predicting the primary disease to improve
efficiency, and put less weight on it when there is an interaction effect to improve the ro-
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bustness. However, simulations in Wang and Shete [2012] showed that this approach no
longer provides unbiased estimation for X − Y association, it losses most of the efficiency
in the SPML approach, and finally it has difficulties to hand additive genetic models. Wang
and Shete [2011] applied a method of moments approach to produce bias-corrected odds
ratio estimates for binary secondary traits using prevalence estimates for the primary and
secondary traits from the literature. Later, they modified their method to add in an in-
teractive effect of the X − Y on the primary disease risk [Wang and Shete, 2012]. The
original version demonstrated the same efficiency as SPML, and same as SPML, it does
not withstand mis-specified P(D|X ,Y ) model assumptions. The modified version improves
the robustness but also losses the efficiency of the original version. To make it worse, this
method requires external information on secondary trait prevalence, it has difficulties to
hand covariates, which largely narrows its applications. He et al. [2011] proposed a Gaus-
sian copula-based approach that models the joint distribution in terms of the marginals for
the primary and secondary phenotypes and uses the multivariate normal distribution to
build in correlation between the phenotypes. Their method can handle multiple correlated
secondary phenotypes, but they did not improve the efficiency of Lin and Zeng [2009]’s
SPML method. Because of these reasons, we do not review theses methods in details in
this paper. In case of interest, one can review their original articles [He et al., 2011; Li and
Gail, 2012; Wang and Shete, 2011, 2012].
For the notation in the literature review, we let X denote the genotype score for an SNP
of interest, Y denote the secondary phenotype, and D={0, 1} denote the primary case-
control status. In a case-control dataset, the data at a single variant consists of n1 cases
{x i, yi, di = 1}, i = 1,2, ...,n1, and n0 controls {x i, yi, di = 0}, i = n1+ 1,n1+ 2, ...,n1+ n0.
We denote n= n1+ n0 as the total sample size.
2.1 Traditional approaches
While the real interest is in P(Y |X ) in the general population, the traditional methods de-
scribed below are attractive because they can be performed using long-established standard
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software, and because they require less model building than more efficient and theoreti-
cally justified approaches. Therefore, it is of interest to determine the situations in which
they might be expected to work adequately.
Four types of traditional methods have been conducted to assess the effects of SNPs
on secondary traits using data from case-control association studies: (1) cases only; (2)
controls only; (3) combined sample of cases and controls; (4) joint analysis of cases and
controls adjusted for the disease status. Methods (1) and (2) are restricted to controls
and cases, respectively. Method (3) ignores the sampling scheme and analyzes cases and
controls together. Method (4) analyzes cases and controls together and includes the disease
status as a covariate in the model.
If the secondary phenotype is not related to the case-control status, or more precisely,
D is independent of Y given X, then all four methods are valid. If the SNP is not associated
with the case-control status, or more precisely, D is independent of X given Y, then all
four methods yield correct estimates from the logistic regression for dichotomous traits
except for the intercept, but the least-squares estimates for quantitative traits produced by
the four methods are biased unless [Nagelkerke et al., 1995]. When the disease is rare,
all standard methods except (1) are approximately valid. However, how rare must it be
for a "rare disease" is unclear to the researchers. It is also clear that method (1) and (2)
are inefficient because they involve discarding the part of the data. Another problematic
situation for method (2) is where an exposure is very rare for controls but rather more
common amongst cases.
In GWAS, most of the secondary traits collected are strongly correlated to the disease
risk to improve efficiency, and therefore any SNPs that are associated with the case-control
status will tend to be detected as being associated with secondary traits by standard meth-
ods even when the latter associations do not exist. It is true that the majority of tested SNPs
in genome are not associated with disease risk, so a standard prospective regression model
provides valid tests of and nearly unbiased estimates of marker-secondary trait associa-
tion. However, when the associations truly exist, all four methods may produce estimates
that are biased toward the null and thus reduce statistical power. These biases have been
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demonstrated in previous researches in Jiang et al. [2006]; Lin and Zeng [2009]; Monsees
et al. [2009]; Richardson et al. [2007]. We also illustrated this problem in motivating
examples in Section 1.1.1 and 1.1.2.
2.2 Inverse-probability-of-sampling-weighted (IPW) approach
The inverse-probability-of-sampling-weighted (IPW) approach is widely used in the field
of secondary analysis for its simplicity. It takes the contributions to the score equations
for fitting a model to prospective data and weight them inversely to their probabilities of






S(β ;Yj|X j) = 0
where S(β ;Yj|X j) is the score function of Y given X , and wi is a weight inverse to their
probabilities of selection. In a random sample of cases and controls, the wi is 1/P(D = i),
and in more complicated sampling designs or post-stratification, wi is a consistent estimator
thereof. Asymptotic variance estimation from linearization involves a sandwich estimator
of the type common to estimating equation methods. Several packages in SAS and R are
available for the implementation of IPW estimation with appropriate variance correction
via the weight statement in PROC GENMOD and weights option in the geeglm() function.
The IPW approach provides unbiased estimates of genotype-secondary trait association
even when both the genotype and secondary trait are independently associated with pri-
mary disease. It can accommodate various types of phenotypes (e.g., binary, continuous
and ordinal) and different models for SNPs (additive, dominant or recessive). It can easily
accommodate covariates, including population substructure, an important confounding in
genetic studies. However, the IPW approach is sensitive to sampling schemes. The result-
ing estimates may not be efficient, especially under complex sampling schemes where the
sampling variables are unrelated to the disease status.
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2.3 Semi-parametric maximum likelihood (SPML) approach
In the SPML approach by Lin and Zeng [2009], they use a generalized linear model to
formulate the effects of X on Y , and write the conditional density of Y given X as P(Y |X ).
If Y is a quantitative trait, they use the linear regression model, and if Y is a dichotomous
trait, they use the logistic regression model, under which
P(Y = 1|X ) = exp(β0+ β1X )
1+ exp(β0+ β1X )
.
In addition, they made the assumption that P(D|X ,Y ) follows the logistic regression model
as follows
P(D = 1|X ,Y ) = exp(γ0+ γ1X + γ2Y )
1+ exp(γ0+ γ1X + γ2Y )
.
Because the sampling is conditional on the case-control status, the likelihood function takes
the retrospective form that
n∏
i=1




{P(Di = 1 | X i,Yi)P(Yi | X i)P(X i)
P(Di = 1)






{P(Yi|X i)p(X i)exp(γ0+ γ1X i + γ2Yi)/(1+ exp(γ0+ γ1X i + γ2Yi))
P(Di = 1)
}Di
× {P(Yi|X i)p(X i)/(1+ exp(γ0+ γ1X i + γ2Yi))
P(Di = 0)
}1−Di
Writ pi = P(X i), and
∑n
i=1 pi = 1. The pi is a nuisance parameter that they treat
non-parametrically and it has potentially high dimensions. They use the profile likelihood
approach to profile out this parameter to improve the computational efficiency. Let the
disease prevalence to be known as ξ, maximizing the retrospective likelihood function is





P(Yi|X i)pi exp(Di(γ0+ γ1X i + γ2Yi))1+ exp(γ0+ γ1X i + γ2Yi)

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subject to two constraints that (1)
∑n







P(y|X i) exp(γ0+ γ1X i + γ2Yi)1+ exp(γ0+ γ1X i + γ2Yi)d y.









Pθ (y|X i) exp(γ0+ γ1X i + γ2Yi))1+ exp(γ0+ γ1X i + γ2Yi)d y −λ2 = 0.
Multiplying the above equation by pi and summing over i, we see λ1ξ+λ2 = n. Therefore,








i=1 pi = 1. Thus, the profile log-likelihood function for β , γ0, γ1 and
γ2 is
l = log L =
n∑
i




Pθ (y|X i) exp(γ0+ γ1X i + γ2Yi))(1+ exp(γ0+ γ1X i + γ2Yi))d y − (n−λ1ξ))},






Pθ (y|X i) exp(γ0+ γ1X i + γ2Yi))(1+ exp(γ0+ γ1X i + γ2Yi))d y − (n−λ1ξ)}
−1 = 1.
They maximize the profile log-likelihood function by the Newton-Raphson algorithm or
optimization algorithms. Likelihood-based statistics (i.e., Wald, score and likelihood-ratio
statistics) can be used to make inference about the parameter of main interest β1.
There are a number of attractive features for the SPML approach. First, when the model
is correctly specified, the SPML approach is by far the most efficient method in estimating
the association between Y and X in the general population. In addition, this approach is
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applicable to both binary and continuous phenotypes, and handle covariates in a flexible
manner. The major disadvantage is that when the disease model is misspecified, the estima-
tion for the association between Y and X is largely biased. One minor disadvantage is that
it is very computationally intensive, especially when considering the continuous covaraites
Z. The probability distribution of the continuous covariates will enter the likelihood func-
tion as a high-dimenstional nuisance parameter, and the the profile-likelihood approach to
eliminate of such nuisance parameters is difficult. A computer program SPREG is avail-
able online http://dlin.web.unc.edu/software/spreg-2/ to perform logistic and
linear regression analysis of secondary trait data in case-control association studies. In ap-
plication, however, it sometimes fails to generate an estimate due to algorithm problems
in their software (further investigated in Section 5.2).
2.4 Quantile regression
Quantile regression first proposed by Koenker and Bassett Jr [1978] is a type of non-
parametric regressions estimating functional relationship between variables for all portions
of a probability distribution. While least square regression estimates the conditional mean
of the response variable given certain values of the predictor variables, quantile regression
aims at estimating either the conditional median or other quantiles of the response variable.
For any real-valued random variable Y with cumulative distribution function F(y) = P(Y ≤
y), the τth quantile of Y is defined as the inverse function
Qτ(Y ) = F
−1(τ) = inf{y : F(y)≥ τ},
where 0 < τ < 1. The median Q1/2(Y ) plays the central role. The loss of quantiles is
defined by the piecewise linear function
ρτ(u) = (τ− I(u< 0))u
21
CHAPTER 2. LITERATURE REVIEW
for some τ ∈ (0,1) as illustrated in Figure 2.4. A specific quantile can be found by mini-
mizing the expected loss Eρτ(Y − by).
Figure 2.1: Quantile regression ρ function.
For a random sample {y1, ..., yn} of Y , the problem of finding the τth sample quantile







Quantiles efficiently describe marginal distribution and minimize asymmetric linear loss.
This leads to the more general methods of estimating models of conditional quantile func-
tions. Least squared regressions offer a template for this development. Knowing that the






suggest that, if we are willing to express the conditional mean of y given x as µ(x) = x Tβ ,





(yi − x Ti β)2.
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ρτ(yi − x Ti βτ)
for any quantile τ ∈ (0,1). A specific regression quantile bβτ can be found by minimizing
the expected loss of (Y−X Tβτ)with respect to βτ. We minimize the expected loss function
by taking the first derivative of it, which generates the estimating equation for the quantile
regression. We let Sτ(X,Y,β) = [τ − I{Y ≤ XTβ}]X be the set of quantile regression
estimating functions. The estimated bβτ minimizes the absolute value of the estimating
function that
bβτ = arg min
β
EY [‖Sτ(X,Y,βτ)‖ | X] = 0.
Quantile regression does not have a parametric likelihood function, and its optimization
is achieved through linear programs, as it can be written as linear function subject to linear
constraints. Statistical software packages are available to conduct quantile analysis such as
quantreg in R and proc quantreg in SAS.
Quantile regression results offer a much richer, more focused view of the applications
than could be achieved by looking exclusively at conditional mean models. First of all, it
offers a systematic strategy for examining how covariates influence the location, scale, and
shape of the entire response distribution. In addition, its estimates are more robust against
outliers in the response measurements in comparison with least squared regressions. Quan-
tile regression is widely used in biostatistics field for various reasons. One, the vulnerable
or high risk group to certain disease often consists of subjects with high or low values for
their quantitative traits. For example, people with high body mass index (BMI) are predis-
posed to diabetes, cancers and many other disorders [Hjartåker et al., 2008]. Therefore,
instead of examining risk factors for the mean of BMI, it is practically meaningful to in-
vestigate the risk factors for the upper quantiles of BMI, which are directly associated with
high risk for many disease. Second, many studies also observe that the covariate effect
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varies across quantile levels. For example, Yang et al. [2012] found that an important
genotype FTO is not only associated with the mean of BMI [Frayling et al., 2007] but also
with the variance, suggesting that the FTO genotype influences the entire distribution of
BMI and impacts differently at various quantiles. As a result, examining covariate effect at
certain or multiple quantiles provides a more comprehensive view of association between
genetic markers and traits. For these reasons, quantile-based analyses have great potential
to deepen and expand the existing knowledge from traditional secondary analysis.
2.5 Major deficiencies of existing approaches
Despite all of the efforts in secondary analysis, a number of deficiencies remain. First,
the performance of the existing methods depends heavily on knowing either the correct
sampling scheme or the P(D|X ,Y ) in the population. However, most case-control stud-
ies are not nested within a larger cohort with clear selection probabilities, and also the
underlying disease model is often unknown. Therefore, there is a need to propose new
methods that are valid and robust in analyzing secondary phenotypes in case-control as-
sociation studies with limited information on the sampling scheme and underlying disease
model. The proposed methods should be generally applicable to a wide range of genetic
models (dominant, recessive and additive), adjust for covariates easily, handle multiple
types of regressions, relax the common conditions of the disease prevalence models, and
be computationally simple and easy to implement.
In addition, extra challenges arise from secondary analysis in non-paramtetric regres-
sions with no likelihood functions, such as quantile regression. The likelihood functions
based approaches mentioned above focus on covariate effects on the mean of secondary
traits, which is only one measure of the central tendency of the outcome, and often re-
quire parametric distribution assumption on the secondary traits. As we have noticed the
attractive features of quantile regression in genetic studies, there is a great need to propose
new methods that could extend quantile regression techniques to estimate the conditional
quantiles of the secondary traits in genetic case-control studies.
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New estimating equation approach
3.1 Notations and settings
Let X denote a genetic variant of interest, Y denote a secondary phenotype, Z denote the
vector of covariates we want to adjust for, and D={0, 1} denote the primary disease status.
The aim of the secondary trait analysis is to estimate the genetic effect of X onto Y in a
general population. A commonly used model can be written as
g(Y ) = β0+ Xβ1+ Z
Tβ2, (3.1)
where g(·) is a link function, and β1 is the coefficient of primary interest. Depending on
the choices of the link function g, Model (3.1) covers a wide range of regressions. If g is an
identity link for continuous outcome that g(Y ) = E[Y | X ,Z], then Model (3.1) is a mean
regression; if g is a logit link for binary outcome that g(Y ) =logit P(E[Y ] = 1 | X ,Z), then
Equation (3.1) is a logistic regression; if g is a quantile function for quantitative outcome
at the τth quantile that gτ(Y ) =QY (τ | X ,Z), then Equation (3.1) is in the form of quantile
regression.
In a case-control dataset, the data consists of n1 cases {x i, z i, yi, di = 1}, i = 1, 2, ...,n1,
and n0 controls {x i, z i, yi, di = 0}, i = n1+1,n1+2, ...,n1+n0. We denote n= n1+n0 as the
total sample size. When both the genotype X and the secondary phenotype Y are associated
with the primary disease D, the association between X and Y often differs between the
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cases and controls. Consequently, directly regressing Y against X using a case-control
sample yields biased estimation of β1. In this thesis, we propose a new estimating equation
based approach to estimate the Model (3.1) for secondary traits from case-control samples.
The new approach utilizes the entire case-control sample, and yields consistent estimation
of β1 in the general population.
3.2 New estimating equations for the secondary pheno-
types in genetic case-control studies
Constructing estimating equations is a common estimation method. Here we define β∗ =
(β∗0 ,β∗1 ,β
∗
2) are the true coefficients in the general population. Then the key of is to find an
estimating function S(X ,Y,Z,β) that for any randomly selected subjects from the general
population, the following equations hold at the true β∗,
EY [S(X ,Y,Z,β
∗) | X ,Z] = 0.





X i(Yi − β0− β1X i − ZTi β2),
which is the first derivative of least square loss function with respect to β1. In the likeli-
hood based regressions, the estimating function S(X ,Y,Z,β) can be constructed as the first
derivative of log-likelihood function, which is also known as Fisher’s score function. Specif-
ically, let L(β ;X ,Y,Z) denote the likelihood function, and then S(X ,Y,Z,β) = ∂ log L(β ;X ,Y,Z)
∂β
.




X i(Yi − exp(β0− β1X i − Z
T
i β2)
1+ exp(β0− β1X i − ZTi β2));
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X i(Yi − exp(β0− β1X i − ZTi β2)).
In regressions with no parametric likelihood functions, S(X ,Y,Z,β) is an estimating
function that minimizes the corresponding loss function. For example, in quantile regres-
sion, we define the loss function by a piecewise linear function at sample τth quantile as
ρτ(u) = (τ− I(u < 0))u. The expected loss function of quantile regression is not differen-




X i[τ− I{Yi ≤ β0,τ+ β1,τX i + Z Ti β2,τ}].
We know the equation EY [S(X ,Y,Z,β
∗) | X ,Z] = 0 holds at true β∗ in the general
population. As we do not have a representative sample of the general population, the
solving the equation directly using case-control sample is biased. we can, however, expand
the equation conditional on the disease status D as follows
EY [S(X ,Y,Z,β
∗) | X ,Z]
=EY [S(X ,Y,Z,β
∗) | X ,Z,D = 0]P(D = 0 | X ,Z) + EY [S(X ,Y,Z,β∗) | X ,Z,D = 1]P(D = 1 | X ,Z)
=0.
(3.2)
This expansion provides the basis of constructing the proposed estimating equations.
Let’s define y˜ as the counter-factual secondary phenotype under alternative disease
status. Specifically, for each subject in the case group, we define y˜i, i = 1, ...,n1, as his or
her phenotype if he or she is actually a control. And for each subject on the control group,
we define y˜i, i = n1+1, ...,n, as his or her phenotype if he or she is actually a case. If we are
able to observe both yi and y˜i ’s, we can then construct the unbiased estimation equations
following the expanded estimating equation (3.2). The sample estimation equations can
27
CHAPTER 3. NEW ESTIMATING EQUATION APPROACH




[S(x i, yi, z i,β)p(di | x i, z i) + S(x i, y˜i, z i,β)p(1− di | x i, z i)] = 0, (3.3)
where p(di|x i,zi) is the probability of being the observed disease status given (x i,zi), and
p(1−di|x i,zi) is the probability of being counter-factual disease status. One can show that
for each summand of Equation (3.3), its conditional expectation given (x i,zi, di) is zero
at the true β∗, and thus constitutes an unbiased estimating equation. Following classical
theories for M- and Z- estimations (Theorems 5.7 and 5.9 in Van der Vaart [2000]), solving
Equation (3.3), Sn(β) = 0, leads to the consistent estimation of β under certain regulation
conditions. The idea of counter-factual outcomes is widely used in causal inference, but
in this application we use counter-factual outcomes to estimate the gene-secondary trait
association rather than making inferences on causality. Although the estimating equations
involve P(D|X ,Z), we are not assuming the disease probability only relates to (X ,Z). In
reality, the disease risk can relate to Y or other auxiliary variables W as well, and p(D|X ,Z)
in Equation (3.3) can be viewed as the marginal probability given (X ,Z), i.e. p(D|X ,Z) =∫
y,w
p(D|X ,Z, y,w)dF(y,w)(y,w), where F(y,w) is the joint distribution of (y,w).
Solving Equation (3) directly is unfeasible since we are unable to observe the counter-
factual secondary outcomes. To get around this difficulty, we propose two approaches. We
first propose a model-based simulation approach to simulate the pseudo counter-factual
observations, and assemble the estimating equations accordingly. In the second approach,
we replace S(x i, y˜i,zi,β) by its conditional expectation over y˜ . In the next two sections,
we elaborate on the two approaches under the assumption that the probability p(di|x i, z i)
is known. An algorithm to estimate p(di|x i, z i) from the case-control sample is provided in
Section 4.5.
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3.3 Estimation Approach A: generating pseudo counter-
factual observations
Under model (3.1), the linear association between Y and (X ,Z) holds among both cases
and controls. The regression coefficients, however, could vary between them. Hence, we
propose to fit Model (3.1) separately for cases and controls, and use the resulting strati-
fied models to simulate pseudo counter-factual outcomes. We define β∗d as the coefficient
functions given disease status D = d such that
β∗d = arg minβ EY [‖S(X ,Y,Z,β)‖ | X ,Z,D = d]. (3.4)






d2) is a vector of the true coefficients conditional on disease status d,















02 as that among controls. We consider two scenarios to illustrate this idea, one
is Generalized Linear Models (GLM) with parametric likelihood functions, and the other is
quantile regression with no parametric form.
Simulating counter-factual outcomes in GLM
When the regressions are based on likelihood functions, one can generate the counter-
factual outcomes from the stratified estimated model of the alternative disease statue. For
example, in logistic regression, we often assume logit link function. Therefore, for each
case yi, we generate its counter-factual outcome from the estimated control model, i.e. b˜yi
is a random draw from a Bernoulli distribution with success probability exp{g0(byi)}/[1+
exp{g0(byi)}]. Likewise, for each control, we generate its counter-factual pseudo outcome
from the estimated case model, where b˜yi is a Bernoulli random variable with success prob-
ability exp{g1(byi)}/[1+ exp{g1(byi)}]. Plugging the pseudo counter-factual outcomes into
the estimating equations (3.3), we could solve for β .
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[S(x i, yi, z i,β)p(di | x i, z i) + S(x i, b˜yi, z i,β)p(1− di | x i, z i)]
 (3.5)
The optimization can be viewed as a weighted regression, where one has 2n observa-
tions, and weights are p(di|x i,zi) for the actual outcomes, and p(1−di|x i,zi) for the pseudo
outcomes. Similar ideas can be applied to other link functions, such as mean regression
with identity link and Poisson regression with log link.
Simulating counter-factual outcomes in Quantile Regression
When the regressions do not have full parametric likelihood functions, one need to con-
sider the main model (3.1) nonparametrically or semi-parametrically across the entire dis-
tribution of Y . For example, in quantile regresssion, which does not assume any parametric
distribution in Y , we need expand the main model (3.1) to the entire quantile process in
order to simulate counter-factual phenotypes. This joint modeling approach has been ex-
plored in recent work, including Wei et al. [2006], to approximate the conditional quantile
function without assuming a parametric likelihood. Specifically, we assume that the linear
quantile model holds for an quantile level τ ∈ (0,1). Under this assumption, we define
β∗(τ | d)d=0,1 as the quantile coefficient functions given disease status D=d such that
β∗(τ | d)d=0,1 = argmin
β
EY
‖Sτ(X ,Y,Z,β)‖ | X ,Z,D = d , (3.6)
for any τ ∈ (0, 1). We let g1,τ(Y ) = β∗0(τ | 1) + Xβ∗1(τ | 1) + ZTβ∗2(τ | 1) define the
conditional quantile function of Y given (X ,Z) among cases, and g0,τ(Y ) = β∗0(τ | 0) +
Xβ∗1(τ | 0) + ZTβ∗2(τ | 0) define that among controls. In what follows, we outline an
estimation algorithm to estimate β∗(τ | d) from the data, and simulate counter-factual
outcomes accordingly. Let 0< τ1 < τ2 < · · ·< τk < 1 be a set of kn evenly spaced quantile
levels.
1. We denote bβ(τk | d), d = 1/0 as the estimated quantile coefficients for β(τk | d) in
Equation (3.6) within cases and controls, respectively.
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2. To approximate the coefficient process β∗(τ | d), we define bβ(τ | d) be a piecewise
linear functions on [0,1] that concatenates the estimates bβ(τk | d) for 0< τ1 < τ2 <
· · ·< τkn < 1 and is subject to the constraint of bβ ′(0 | d) = bβ ′(1 | d) = 0.
3. For the ith subject, i = 1, . . . ,n, we simulate its pseudo outcome eyi by beyi = bβ0(ui |
1−di)+ bβ1(ui | 1−di)X +ZT bβ2(ui | 1−di), where ui is a random draw from Uniform
(0,1) distribution.
The simulated beyi ’s follows the model-estimated conditional distribution of yi given
(x i,zi) and di. Under certain mild conditions as outlined in Wei et al. [2006], bβ(τ | 1)
and bβ(τ | 0) uniformly converge to the underlying true ones over the interval [1/(kn +
1), kn/(kn+1)] as n1 and n2 go to the infinity. Hence, with a reasonably large sample sizes,
the simulated beyi approximates the counter-factual outcome eyi well.
No matter the regression have likelihood functions or not, we are able to generated
simulated b˜yi. With b˜yi, we construct the sampling estimating equations as
n∑
i=1
[S(x i, yi, z i,β)p(di | x i, z i) + S(x i, b˜yi, z i,β)p(1− di | x i, z i)] = 0. (3.7)
Simulating pseudo outcomes is subject to sampling uncertainty, and brings extra vari-
ability into parameter estimation. To further stabilize the variance, we suggest to repeat
the above simulation procedures T time, and use their average as final estimation. Let bβ (t)n
as the estimated coefficients from the t-th replicate, we then use the average of bβ (t)n as the
final estimate of the coefficients. i.e.
bβ n = T−1 T∑
t=1
bβ (t)n .
Similar to the multiple imputation technique that is commonly used to handle missing
data, the variance of bβ n is fairly stable with a small number of T between 5 and 10. We
will demonstrate the effect of different T in the section of simulations. In the rest of paper,
we call bβ n the SICO estimate since it uses SImulated Counter-factual Outcomes.
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3.4 Estimation Approach B: estimating S(X ,Y,Z,β) by its
conditional expectation
An alternative approach to circumvent the difficulty of unobserved y˜i is to take the condi-
tional expectation of S(x i, y˜i,zi,β) over y˜i. One can easily show that the following esti-




[S(x i, yi,zi,β)p(di | x i,zi) + E y˜i{S(x i, y˜i,zi,β)|x i,zi}p(1− di | x i,zi)] = 0.
(3.8)
When S(x i, y˜i,zi,β) is linear in y˜i
In a special case that the estimating function S(x i, y˜i,zi,β) is linear in y˜i, this approach
is particularly appealing since one can simply replace y˜i by its conditional mean. In this




[S(x i, yi, z i,β)p(di | x i, z i) + S{x i, E( y˜i|x i,zi),zi,β}p(1− di | x i, z i)] = 0.
(3.9)
The conditional mean E( y˜i|x i, zi) can be easily estimated from stratified least square re-
gression. Specifically, one can regress yi against x i and zi separately among cases and
controls, and estimate E( y˜i|x i,zi) by the predicted value under alternative disease status





S(x i, yi,zi,β)p(di|x i,zi) + S{x i, bE( y˜i|x i,zi),zi,β}p(1− di|x i,zi)= 0,
(3.10)
where bE( y˜i|x i,zi) is the predicted outcome given x i and zi under the alternative disease
status. We can define eβ n as resulting estimate from conditional expectation of S(X , eY ,Z,β).
Then
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S(x i, yi,zi,β)p(di|x i,zi) + S{x i, bE( y˜i|x i,zi),zi,β}p(1− di|x i,zi)
 .
(3.11)
Similar as in the first approach, this optimization is equivalent to weighted linear re-
gression where the weights are p(di|x i, zi) for the actual outcomes, and are p(1− di|x i, zi)
for the bE( y˜i|x i,zi).
When S(x i, y˜i,zi,β) is not linear in y˜i
When the estimating function S(x i, y˜i,zi,β) is not linear in y˜i, we are unable to pass
the expectation into the estimating function. In a simple scenario where we have sufficient
number of cases and controls given each value of (x i,zi), we could estimate the expectation
terms by
bE y˜i[S(x i, y˜i,zi,β)|x i,zi] =
∑n1+n2
j=n1+1
I(x j = x i)I(z j = zi)S(x j, y j,z j,β)∑n1+n2
j=n1+1
I(x j = x i)I(z j = zi)
, i = 1, ...,n1;
bE y˜i[S(x i, y˜i,zi,β)|x i,zi] =
∑n1
j=1 I(x j = x i)I(z j = zi)S(x j, y j,z j,β)∑n1
j=1 I(x j = x i)I(z j = zi)
, i = n1+ 1, ...,n
(3.12)
where I(·) is an indicator function. These are essentially the sample means of the
estimating function with the same (x i,zi) but alternative diseases status. Following the
law of large numbers, both estimates converge to the true expectations with
p
n rate. Such
applications can be found in single loci analysis in genetic studies [Kraft, 2007]. In more
general scenarios, especially when Z includes continuous variables, the indicator function
no longer produces valid estimates, since we may have very few observations at a given
value of Z. We propose to replace it by some suitable kernel function Kh(·) with bandwidth
h, and approximate the expectation by
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bE y˜i[S(x i, y˜i,zi,β)|x i,zi] =
∑n1+n2
j=n1+1
I(x j = x i)Kh(‖z j = zi‖)S(x j, y j,z j,β)∑n1+n2
j=n1+1
I(x j = x i)Kh(‖z j = zi‖)
, i = 1, ...,n1;
bE y˜i[S(x i, y˜i,zi,β)|x i,zi] =
∑n1
j=1 I(x j = x i)Kh(‖z j = zi‖)S(x j, y j,z j,β)∑n1
j=1 I(x j = x i)Kh(‖z j = zi‖)
, i = n1+ 1, ...,n
(3.13)




[S(x i, yi, z i,β)p(di | x i, z i) + bE y˜i{S(x i, y˜i, z i,β) | x i,zi}p(1− di | x i, z i)] = 0.
(3.14)
The eβ n is the solution to this equation. It is equivalently as




[S(x i, yi, z i,β)p(di | x i, z i) + bE y˜i{S(x i, y˜i, z i,β) | x i,zi}p(1− di | x i, z i)]

(3.15)
Note that the estimates in (3.12) - (3.13) are linear functions of the original regression
estimating functions. Hence one could reorganize the estimating functions (3.14) as
bSn(β) = n1∑
i=1
wiS(x i, yi,zi,β) +
n∑
j=n1+1
w jS(x j, y j,z j,β)
where
wi = p(di = 1|x i,zi) +
n1+n2∑
j=n1+1
I(x j − x i)Kh(‖z j − zi‖)p(d j = 1|x j,z j)∑n1
i=1 I(x j − x i)Kh(z j = zi)
and
w j = p(d j = 0|x j,z j) +
n1∑
i=1
I(x i − x j)Kh(‖zi − z j‖)p(di = 0|x i,zi)∑n
j=n1+1
Kh(‖x i − x j‖) .
Since the weights wi are not functions of β , solving the working estimating equations is
equivalent to a weighted regression and is computationally straightforward.
Finally, to choose an optimal bandwidth or a kernel function in (3.13), we propose to
use K-fold cross-validation. Specifically, we randomly partition the data into K subsets and
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denote eβ (−`)(h) as the estimated coefficients using bandwidth h without the the `th subset







wiL{x i, yi,zi, eβ (−`)(h)}+∑
j∈Γ`
w jL{x j, y j,z j, eβ (−`)(h)} ,
where C` is the index set for the `-th case subset, Γ` is the index set for the `-th control
subset, andL (x , y,z,β) is the loss function. For example, in least square mean regression,
L (x , y,z,β) = (y − β0 − xβ1 − zTβ2)2; in quantile regression, Lτ(x , y,z,β) = (y − β0 −
xβ1 − zTβ2){τ− I(y − β0 − xβ1 − zTβ2 < 0)}. Essentially, we choose the bandwidth that
minimizes the weighted cross-validated regression loss functions.
We call eβ n in Approach B as the CE estimates, since the Conditional Expectation is
used to estimate the estimating function. Both SICO and CE estimates are consistent and
asymptotic normal. One can refer Wei et al. [2015] for the large sample properties of
the proposed estimators. When the dimension of (x ,z) increases or when covariate space
is sparse, the kernel smoothing in the approach B could be difficult due to the curse of
dimensionality. Approach A avoids the smoothness, and hence is readily applicable for any
dimension of (x ,z). However, it makes a stronger assumption of the linear model. For
quantile regression, the linear model needs to be hold for the entire quantile process. This
assumption could be relaxed by using more general models such as semiparametric partly
linear models.
3.5 Estimation of p(di|x i,zi)
In the aforementioned two estimation algorithms, we assumed that the conditional dis-
ease probability p(di|x i,zi) is known. In practice, it needs to be estimated. To estimate
p(di|x i,zi), we could use the model in primary analysis or assume a logistic model as fol-
lows:
P(D = 1|X ,Z) = exp(γ0+ Xγ1+ ZTγ2)/{1+ exp(γ0+ Xγ1+ ZTγ2)}. (3.16)
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Note that model (3.16) is a working model to approximate the distribution of disease given
(X ,Z) and may differ from the true disease model because the secondary outcome Y may
also affect disease risk. In our simulation study in later section, we consider three disease
models that are based on Y .
Further note that the intercept γ0 cannot be consistently estimated directly form the
case-control data, and needs to be calibrated to yield valid estimation of p(di|x i,zi) [Pren-
tice and Pyke, 1979]. Assuming that the overall disease prevalence in the general popula-




exp(γ0+ Xbγ1+ ZTbγ2)/{1+ exp(γ0+ Xbγ1+ ZTbγ2)}dFXZ, (3.17)
where FXZ is the joint distribution of X and Z, and bγ1 and bγ2 are the estimated γ1 and γ2
from logistic regression. When the joint distribution FXZ is difficult to obtain, we propose







exp(γ0+ x ibγ1+ zTi bγ2)/{1+ exp(γ0+ x ibγ1+ zTi bγ2)}
!2
(3.18)
Both Equation (3.17) and (3.18) are univariate optimization. Therefore, obtaining bγ0 from
either equation is computationally easy. The estimate of the conditional disease probability
p(di|x i,zi) can be written as bp(di|x i,zi) = exp(bγ0+bγ1X+ZTbγ2)/{1+exp(bγ0+bγ1X+ZTbγ2)}.
When the working model or disease prevalence P0 is mis-specified, the resulting bγ0 could
be slightly biased. The simulation studies in Section 4.5 show the results on the estimation
of the coefficients when the prevalence the working model or P0 is mis-specified.
3.6 Bootstrap procedure for the confidence intervals and
hypothesis tests
In Sections 3.3 and 3.4, we outlined two estimation algorithms to estimate the parameters
in Model (3.1). Although both SICO and CE estimates can be viewed as some form of
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weighted regressions, the direct output of Wald test statistics does not apply, because it
does not take into consideration of the uncertainty from the estimated p(d|x ,z), simulated
y˜i and the kernel smoothness. In addition, it is the difficult to estimate asymptotic vari-
ances by any analytically tractable form [Wei et al., 2015]. Therefore, we propose to use
bootstrap method to obtain the bootstrap standard error of our proposed estimates. With
the bootstrap standard error, we are able to construct bootstrap confidence intervals and
apply Wald test statistics to test the null hypothesis, say H0 : β1 = 0, i.e. whether the ge-
netic variant(s) are associated with the secondary phenotype Y in the general population.
The Bootstrap test statistics is written as follows:
(bβ1− β∗1)2
var(bβ1) ∼ χ21 (3.19)
We elaborate the bootstrap procedure as follows:
1. Bootstrap cases and controls separately to assemble a bootstrap case-control sample.
In details, we randomly select n1 cases from case sample and n0 controls from control
sample with replacement.
2. For each bootstrap sample, we re-apply the proposed algorithm to obtain bootstrap
estimates. For SICO estimator, that includes re-generating pseudo-outcomes y˜i and re-
estimating p(d|x i,zi) . For CE estimator, that includes re-estimating E y˜i[S(x i, y˜i,zi,β)]
and p(d|x i,zi).
3. We repeat steps 1 and 2 B times, then calculate the bootstrap standard error. We
use the bootstrap standard error to construct confidence intervals and bootstrap Chi-square
test statistics for inference.
We evaluated the type I error of this bootstrap procedure using simulations in Section





4.1 Finite sample performance with GLM
In this section, we present several numerical studies to investigate the finite sample perfor-
mance of the proposed estimation method under the GLM framework with comparison to
comparable existing methods. We simulate the data mimicking the loci-to-loci comparison
in GWA case-control studies.
Model settings: Same as before, we denote by D = {0, 1} the primary disease status, by
X = {0,1, 2} a single SNP (under additive model) with minor allele frequency (MAF) 0.3,
and by Z a covariate of interest following a standard normal distribution. The correlation
coefficient between X and Z is set to be 0.3. We consider both binary and continuous
secondary phenotypes Y . For binary Y , we assume a linear logistic model. We consider
both binary secondary and continuous phenotypes Y . For binary Y , we consider a the
following logistic model:
P(Y = 1|X , Z) = exp(−1+ 0.2X + 0.1Z)
1+ exp(−1+ 0.2X + 0.1Z) (4.1)
For continuous Y with homoscedastic error, we consider a linear model as follows:
Y = 1+ 0.2X + 0.1Z + e (4.2)
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In Equation (4.1), the prevalence of Y is approximately 30%. In Equation (4.2), the
error term follows independent and identically distributed (i.i.d.) normal distribution that
e ∼ N(0, 1). Since the genetic effects are often small in GWAS, we choose β∗1 = 0.2 as the
true coefficient of X in predicting Y .
To model the disease probability P(D|X ,Y, Z), we consider three possible settings. Set-
ting 1 (Logistic Setting) assumes the probability of disease follows a linear logistic model
with main effects of X and Y . Similar settings were considered in Lin and Zeng [2009] for
SPML and Wang and Shete [2011] for bias correction approach. Setting 2 (Interaction Set-
ting) extends the Logistic Setting by including the interactive term between X and Y . Sim-
ilar settings were considered in Li and Gail [2012]’s paper for adaptive weighted approach
and Wang and Shete [2012]’s paper for modified bias correction approach. Finally, Setting
3 (Piecewise Setting) assumes that P(D|X ,Y, Z) follows piecewise linear model instead of
logistic regression. The detailed mathematical forms of the disease models are given below.
The U1 and U2 are the 0.25th and 0.75th quantiles of the 0.3X + log(2)Y + log(2)Z .
• Setting 1 (Logistic Setting):
P(D = 1|X ,Y, Z) = exp(γ0+ 0.3X + log(2)Y + log(2)Z)
1+ exp(γ0+ 0.3X + log(2)Y + log(2)Z)
• Setting 2 (Interaction Setting):
P(D = 1|X ,Y, Z) = exp(γ0+ 0.3X + log(2)Y + log(2)Z + 0.2XY )
1+ exp(γ0+ 0.3X + log(2)Y + log(2)Z + 0.2XY )
• Setting 3 (Piecewise Setting):
P(D = 1|X ,Y, Z) =

0.05, 0.3X + log(2)Y + log(2)Z ≤ U1
0.05+ 0.10.3X+log(2)Y+log(2)Z−U1
U2−U1 , U1 < 0.3X + log(2)Y + log(2)Z ≤ U2
0.15, 0.3X + log(2)Y + log(2)Z > U2
The prevalence of the primary disease (P0) is set to be 10%. The intercepts γ0 in these
models are selected to match the overall disease prevalence in the population. For each of
39
CHAPTER 4. SIMULATION STUDIES
the model settings above, we first generate a large number of observations (N = 500, 000),
which we treat as a general population. From the initial sample, we first randomly draw
500 cases and 500 controls to mimic a small case-control study, and then increase 2000
cases and 2000 controls for a large case-control study. The selection is under simple sam-
pling scheme, which means the selection probability only depends on the disease status.
For the logstic regression, we evaluate the finite sample performance of the proposed meth-
ods with SICO and CE estimates. For linear regression, because CE estimate is very simple
with only one-step optimization, we only evaluate the finite sample performance of CE
estimates. We compared the resulting estimates with traditional methods, IPW and SPML
approaches. We select IPW and SPML approaches because considering the current avail-
able secondary analysis methods, the IPW method is the most simple and robust method,
and SPML is the most efficient method when its model assumption is satisfied. For SICO
estimate, we vary the T values from 1 to 100 (T is the number of pseudo samples gener-
ated) and compare their estimates. In the CE estimation for logistic regressions, we use
a kernel function Kh((x1, z1)T , (x2, z2)T ) = I(x1 = x2)exp{−(z1 − z2)2/h}, where h is the
bandwidth selected by the 5 fold cross-validation.
Comparison Methods: We estimated the coefficients under the different settings above
using the following methods:
(1) regression using cases only,
(2) regression using controls only,
(3) regression using combined case-control sample without adjustment,
(4) regression using case-control sample adjusting for primary disease status ,
(5) IPW,
(6) SPML,
(7) our proposed SICO estimator (in logistic models),
(8) our proposed CE estimator (in both logistic and linear models).
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Results and discussions: Tables 4.1 to 4.2 summarize the relative bias, standard er-
ror and mean squared error of the estimated coefficients β1 based on 500 Monte-Carlo
replicates from logistic model and linear model, respectively. According to the tables, the
traditional methods, including direct regressions applied to case only, control only, the
combined case-control sample , and combined case-control sample adjusting for primary
disease status, are all biased in all settings we consider. Hence, without appropriate adjust-
ment, traditional methods are easy to provide biased estimation for the X − Y association
in genetic case-control data.
Both SICO and CE estimates produce fairly accurate estimates in all the models. In
SICO, the estimated coefficients are unbiased even with T = 1. The standard errors do
decrease slightly as T increases, but they quickly stabilize after T = 10. Therefore, we
conclude that a relatively small number of imputations is enough to reach the optimal ef-
ficiency of this approach and it is computationally efficient. The CE estimates are obtained
using one-step optimization in linear model, and kernel smoothing techniques in logistic
model. We could observe the SICO estimates perform better than CE estimates in logis-
tic model when CE estimates requires smoothness. Overall, it suggests that the proposed
estimating equation approach works well in performing unbiased secondary analysis in
case-control studies.
The IPW performs well in correcting the bias in all settings we consider. The calculation
of IPW method requires the information on sampling scheme. Under the simple sampling
scheme, where the selection of cases and controls solely depends on the disease status, it is
equivalent to use the disease prevalence as in the proposed methods. Therefore, it’s perfor-
mance is comparable to the proposed estimates. We will consider additional comparison
under complex sampling scheme later in Section 4.3.
The SPML approach provides efficient unbiased estimations when the linear logistic
model assumption is satisfied but introduces biases when violated. In details, Under the
Logistic Setting, the SPML estimate is of most efficiency of all methods we consider. Under
Interaction and Piecewise Settings, when the linear logistic model assumption is violated,
the SPML estimates contain considerable bias.
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In our algorithm, we assume the working model as P(D|X , Z) = exp(γ0+γ1X+γ2Z)/(1+
exp(γ0+γ1X+γ2Z)). It is different from generated data that is based on three P(D|X ,Y, Z)
settings. Although under the mis-specified P(D|X , Z), the proposed estimating equation
based approach performances fairly well, which shows the proposed approach is quite ro-
bust to the P(D|X , Z) model mis-specification. In Section 4.5, we will consider additional
scenarios to test the robustness boundary of bP(D|X , Z).
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Logistic Interaction Piecewise
n Method RB (%) SE MSE ×n RB (%) SE MSE ×n RB (%) SE MSE×n
2000 Case -13.3 0.067 10.2 66.3 0.064 42.4 -36.5 0.072 21.4
Control -10.2 0.085 15.3 -30.1 0.081 20.9 3.5 0.081 13.3
CC 10.4 0.050 5.9 61.4 0.050 34.4 -12.0 0.056 7.5
Adj CC -12.1 0.051 6.2 26.9 0.051 10.6 -18.1 0.056 9.1
IPW 0.3 0.072 10.5 2.0 0.069 9.5 1.1 0.073 10.5
SPML 0.5 0.050 5.0 46.5 0.050 21.7 -15.5 0.056 8.3
SICO (T=1) -0.4 0.082 13.6 -0.8 0.076 11.7 0.9 0.080 12.9
SICO (T=10) -0.5 0.074 10.8 -0.5 0.071 10.0 0.9 0.073 10.8
SICO (T=100) -0.5 0.073 10.6 -0.4 0.070 9.8 0.6 0.073 10.6
CE -6.0 0.076 11.8 -7.8 0.072 10.9 -0.4 0.073 10.6
500 Case -19.6 0.145 11.2 54.5 0.138 15.5 -44.7 0.137 13.3
Control -14.6 0.156 12.5 -27.0 0.168 15.5 6.7 0.152 11.5
CC 4.0 0.107 5.8 55.4 0.103 11.4 -15.7 0.101 5.6
Adj CC -17.9 0.107 6.4 21.3 0.104 6.3 -20.9 0.102 6.0
IPW -4.2 0.134 9.0 2.9 0.141 9.9 2.7 0.134 8.9
SPML -5.3 0.107 5.8 40.7 0.102 8.5 -18.6 0.101 5.8
SICO (T=1) -5.6 0.152 11.5 -0.8 0.163 13.3 1.8 0.152 11.5
SICO (T=10) -4.2 0.139 9.7 2.3 0.143 10.2 2.0 0.134 9.0
SICO (T=100) -4.9 0.137 9.4 0.8 0.144 10.3 2.1 0.135 9.1
CE -10.6 0.138 9.8 -9.7 0.148 11.1 1.5 0.136 9.2
Table 4.1: The relative bias (RB), standard error (SE) and mean squared error (MSE) of
the estimated coefficient β1 in logistic model. The true value β
∗
1 = 0.2. "Case" stands for
unadjusted logistic regression using case sample only. "Control" stands for unadjusted lo-
gistic regression using control sample only. "CC" stands for unadjusted logistic regression
using both case and control samples. "Adj CC" stands for logistic regression using both case
and control samples adjusting for primary disease status. "IPW" stands for inverse proba-
bility weighted logistic regression. "SPML" stands for semi-parametric maxmium likelihood
based logistic regression. "SICO (T)" stands for proposed SICO estimates with T replicate.
"CE" stands for proposed CE estimates using kernel smoothing techniques.
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Logistic Interaction Piecewise
n Method RB (%) SE MSE ×n RB (%) SE MSE ×n RB (%) SE MSE×n
2000 Case -24.8 0.031 6.8 13.3 0.032 3.6 -27.6 0.032 7.9
Control -10.6 0.037 3.5 -34.7 0.035 11.8 0.5 0.036 2.6
CC 12.8 0.024 2.5 52.7 0.025 23.8 -8.6 0.024 1.7
Adj CC -18.6 0.023 3.7 -8.4 0.024 1.6 -14.2 0.024 2.6
IPW 1.6 0.032 2.1 -0.8 0.031 1.9 -0.5 0.032 2.0
SPML 0.2 0.026 1.3 28.3 0.024 7.7 -12.1 0.024 2.2
CE 0.6 0.033 2.1 0.6 0.033 2.1 -0.7 0.032 2.1
500 Case -23.3 0.065 3.2 0.4 0.062 1.9 -23.4 0.066 3.3
Control -11.4 0.068 2.6 -35.7 0.075 5.3 0.3 0.071 2.5
CC 11.5 0.046 1.3 45.8 0.051 5.5 -5.9 0.050 1.3
Adj CC -18.2 0.046 1.7 -16.1 0.049 1.7 -11.9 0.049 1.5
IPW 0.4 0.060 1.8 -3.1 0.066 2.2 0.0 0.064 2.1
SPML -1.2 0.046 1.0 21.1 0.049 2.1 -9.7 0.050 1.4
CE -0.8 0.060 1.8 -8.0 0.067 2.3 -0.4 0.064 2.1
Table 4.2: The relative bias (RB), standard error (SE) and mean squared error (MSE) of the
estimated coefficient β1 in linear model. The true β
∗
1 = 0.2. "Case" stands for unadjusted
linear regression using case sample only. "Control" stands for unadjusted linear regression
using control sample only. "CC" stands for unadjusted linear regression using both case
and control samples. "Adj CC" stands for linear regression using both case and control
samples adjusting for primary disease status. "IPW" stands for inverse probability weighted
linear regression. "SPML" stands for semi-parametric maxmium likelihood based linear
regression. "CE" stands for proposed CE estimates using one-step optimization.
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4.2 Finite sample performance with quantile regression
In this section, we present the numerical studies for the finite sample performance of the
proposed estimates under the quantile regression framework. Since quantile regression
does not have a parametric likelihood assumption of the data, the estimating approach is
considerable different from the ones for GLM. The notation is the same as before that we
let D = {0, 1} denote the primary disease status, X = {0, 1,2} denote a single SNP (under
additive model) with minor allele frequency (MAF) 0.3, and Z ∼ N(0,1) denote a covariate
of interest. For the heteroscedastic continuous Y , we consider the following location scale
model:
Y = 1+ 0.12X + 0.1Z + (1+ 0.02X )e (4.3)
For the error term e, we consider both normal and skewed distributions. In details,
e ∼ N(0,1) in Quantile Model (1) and e ∼ χ21/
p
2 in Quantile Model (2). We scale ei
in Quantile Model (2) so that it has the same error variance as in Quantile Model (1)
to standardize the signal-to-noise ratio. According to the Equation (4.3), the covariate
effect of X is stronger on the upper quantiles than the lower ones, while the covariate Z
has constant effect at all the quantile levels. Specifically, the true X coefficient is 0.12+
0.02Qei(τ) at the τth quantile, and the true Z coefficient is 0.1 at all quantiles. The disease
model for P(D|X ,Y, Z) considered here is similar to the Logistic Setting that the disease
prevalence follows linear logistic model (shown below). The only difference is that we
adjust γ0 to let the disease prevalence P0 = 5%.
P(D = 1|X ,Y, Z) = exp(γ0+ 0.3X + log(2)Y + log(2)Z)
1+ exp(γ0+ 0.3X + log(2)Y + log(2)Z)
For both Quantile Model (1) and (2), we first simulate 500 cases and 500 controls to
mimic a small case-control study, and then increase 2000 cases and 2000 controls for a
large case-control study. Since the performance at different quantile levels may vary, we
estimate the X − Y associations at five different quantiles τ= (0.1, 0.25, 0.5, 0.75, 0.9) si-
multaneously. The estimates for τ= 0.5 and 0.9 are shown in the tables to demonstrate the
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performance at different quantiles. The selection of the best bandwidth for kernel smooth-
ing in CE estimates is particular tricky in quantile regressions, as a bandwidth might be
optimal for one quantile but not another. Therefore, in addition to 5-fold cross-validation
we used in Section 4.1, we further investigate the effects of bandwidths on estimation by
using the fixed bandwidths. In details, we repeatedly apply the proposed estimation pro-
cedure to a sequence of fixed bandwidths, ranging from 0.02 to 100, and then evaluate
the resulting mean absolute bias with each bandwidth. To see whether the estimates from
smaller sample sizes are more sensitive to bandwidth selection, we repeat this procedure
on a subset of 500 cases and 500 controls.
Table 4.3 and 4.4 summarize the relative bias, standard error and mean squared error of
the estimated quantile coefficients at quantile levels 0.5 and 0.9. Similar as in Section 4.4,
the estimated quantile coefficients from the unadjusted traditional methods are seriously
biased. Both the SICO and CE estimators produce fairly accurate estimates in all the models
and at all the quantile levels with all the relative biases being controlled within 5%. Since
we sample cases and controls solely depends on the disease status, the IPW also performs
well in controlling the bias as expected. The mean squared errors of the SICO estimates
(T ≥ 10) are slightly smaller than IPW ones in all four scenarios. Overall, it suggests that
the proposed estimating equation approach works well in performing unbiased secondary
quantile analysis in case-control studies.
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τ= 0.5 τ= 0.9
n RB (%) SE MSE ×n RB (%) SE MSE ×n
500 Case 12.2 0.087 3.9 4.7 0.116 6.7
Control -7.3 0.089 4.0 -6.1 0.122 7.4
CC 41.0 0.064 3.2 31.0 0.086 4.8
IPW 0.1 0.084 3.5 2.0 0.112 6.3
SICO (T=1) -0.6 0.088 3.9 -0.6 0.116 6.7
SICO (T=10) -1.3 0.082 3.4 -2.9 0.105 5.5
SICO (T=100) 4.1 0.081 3.3 5.4 0.104 5.4
CE 0.3 0.086 3.7 -0.3 0.114 6.5
2000 Case 10.8 0.041 3.8 -0.6 0.055 6.0
Control -13.0 0.044 4.3 -13.2 0.060 8.0
CC 39.4 0.032 6.5 25.2 0.043 6.4
IPW -4.8 0.042 3.6 -2.5 0.056 6.3
SICO (T=1) -4.6 0.047 4.4 -1.9 0.064 8.1
SICO (T=10) -3.5 0.042 3.5 -1.6 0.055 6.0
SICO (T=100) -3.9 0.042 3.5 -2.0 0.055 6.0
CE -4.7 0.042 3.6 -2.0 0.056 6.3
Table 4.3: The relative bias (RB), standard error (SE) and mean squared error (MSE) of
the estimated quantile coefficient in Quantile Model (1). The true β1,τ is 0.12+0.02Qei(τ).
In Quantile Model (1), ei ∼ N(0,1). "Case" stands for unadjusted quantile regression using
case sample only. "Control" stands for unadjusted quantile regression using control sample
only. "CC" stands for unadjusted quantile regression using both case and control samples.
"IPW" stands for inverse probability weighted logistic regression. "SICO (T)" stands for
proposed SICO estimates with T replicate. "CE" stands for proposed CE estimates using
kernel smoothing techniques.
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τ= 0.5 τ= 0.9
n RB (%) SE MSE ×n RB (%) SE MSE ×n
500 Case -34.7 0.184 17.9 -102.2 0.372 82.1
Control -2.5 0.048 1.2 -19.0 0.197 19.8
CC 36.6 0.072 3.7 57.9 0.291 46.6
IPW 1.3 0.049 1.2 4.3 0.201 20.2
SICO (T=1) 2.2 0.054 1.5 8.0 0.224 25.1
SICO (T=10) 1.5 0.048 1.2 3.5 0.198 19.5
SICO (T=100) 1.6 0.048 1.1 2.8 0.194 18.9
CE 2.6 0.051 1.3 5.0 0.204 20.7
2000 Case -28.8 0.086 17.4 -111.9 0.184 130.0
Control -1.7 0.025 1.3 -22.3 0.102 23.2
CC 39.1 0.035 7.3 50.6 0.141 52.6
IPW 2.0 0.025 1.3 0.2 0.099 19.6
SICO (T=1) 2.7 0.028 1.6 0.0 0.108 23.1
SICO (T=10) 2.0 0.026 1.3 0.2 0.098 19.3
SICO (T=100) 2.1 0.025 1.3 0.5 0.096 18.5
CE 2.2 0.026 1.4 -0.9 0.100 19.8
Table 4.4: The relative bias (RB), standard error (SE) and mean squared error (MSE) of
the estimated quantile coefficient in Quantile Model (2). The true β1,τ is 0.12+0.02Qei(τ).
In Quantile Model (2), ei ∼ χ21/
p
2. "Case" stands for unadjusted quantile regression using
case sample only. "Control" stands for unadjusted quantile regression using control sample
only. "CC" stands for unadjusted quantile regression using both case and control samples.
"IPW" stands for inverse probability weighted quantile regression. "SICO (T)" stands for
proposed SICO estimates with T replicate. "CE" stands for proposed CE estimates using
kernel smoothing techniques.
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In Figure 4.1, we plot the mean absolute biases of the estimated quantile coefficients
from Quantile Model (1) against the logarithm of their corresponding bandwidths. The
horizontal line is the mean absolute bias of the estimated coefficients with CV selected
bandwidth. Similarly, we plot in Figure 4.2 the mean absolute biases with fixed and CV
selected bandwidth from Quantile Model (2). We found that the biases are well controlled
within 0.02 regardless of the selection of bandwidth. Hence we conclude that the proposed
method is not sensitive to the choice of bandwidth. The estimates are close for a fairly wide
range of bandwidth. The estimates using CV selected optimal bandwidth outperform most
of those with fixed bandwidths, which suggested that the proposed bandwidth selection
works reasonably well. The advantage of CV selected bandwidth is more visible at the
0.5th quantile in Quantile Model (1) when the outcome is normally distributed, and at
0.1th quantile in Quantile Model (2) when the outcome follows χ2 distribution. In other
words, the selection is more helpful for the quantile levels at which the density is higher.
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Figure 4.1: Mean absolute biases of the estimates with different bandwidths from Quantile
Model (1). The horizontal line is the mean absolute bias of the estimated coefficients with
CV selected bandwidth. The dots are the mean absolute biases of the estimated quantile
coefficients with fixed bandwidths.
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Figure 4.2: Mean absolute biases of the estimates with different bandwidths from Quantile
Model (2). The horizontal line is the mean absolute bias of the estimated coefficients with
CV selected bandwidth. The dots are the mean absolute biases of the estimated quantile
coefficients with fixed bandwidths.
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4.3 Further comparison with IPW under complex sampling
schemes
The inverse-probability-weighting (IPW) technique has demonstrated comparable efficiency
in Section 4.1 and slightly worse efficiency in Section 4.2 in comparison with SICO esti-
mates for the secondary analysis of case-control data. The validation of IPW estimates,
however, relies on a correct specification of the selection probabilities, which is often un-
known unless nested within a large cohort study. In Section 4.1 and 4.2, we consider the
simple sampling scheme that the selection probability only depends on the disease status.
We have a representative random disease sample and a representative random control sam-
ple. In such case, the selection probability is homogeneous for all the cases and for all the
controls, and IPW works well. In this section, we consider a complex sampling scheme that
there exists an independent ancillary variable w following N(0, 1), and we oversample the
subjects with w > 0. Specifically, the observations with positive w are 9 times more likely
to be selected into the sample than subjects with w < 0 in both cases and controls. The
second sampling scheme is known as stratified sampling, and is commonly used in survey
designs for various reasons. For example, the National Maternal and Infant Health Survey
oversampled the infants born with low birthweight (≤ 2500 g) and very low birthweight
(≤1500 g) for the great research interests on the long term and short term health outcomes
of these infants. We evaluate the finite sample performance of IPW in comparison with the
proposed SICO and CE estimators under this condition.
Table 4.5 shows the relative bias, standard error, and mean squared error of the esti-
mated coefficient β1 under complex sampling scheme from 500 Monte-Carlo samples. We
observe that when the positive w is over sampled, the IPW estimates suffer from inflated
variance and bias, especially in quantile models. The proposed estimates are unaffected.
As long as Y is a random sample given (D,X , Z), the resulting estimates are less affected
by sampling schemes.
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Logistic Interaction Piecewise
Model Method RB (%) SE MSE ×n RB (%) SE MSE ×n RB (%) SE MSE×n
LogR IPW 4.7 0.119 28.4 4.5 0.114 26.0 -1.5 0.112 25.0
SICO (T=1) 0.8 0.080 12.9 0.1 0.081 13.0 -1.5 0.079 12.4
SICO (T=10) 0.4 0.073 10.7 -1.4 0.072 10.5 -1.9 0.072 10.4
SICO (T=100) 0.8 0.073 10.5 -1.4 0.072 10.4 -1.9 0.072 10.2
CE -3.7 0.074 11.2 -9.5 0.073 11.5 -1.9 0.072 10.3
LR IPW 0.5 0.053 5.7 -0.7 0.048 4.6 0.0 0.052 5.5
CE 1.2 0.033 2.1 0.1 0.031 2.1 -0.7 0.031 1.9
Table 4.5: The relative bias (RB), standard error (SE) and mean squared error (MSE) of
the estimated coefficient β1 for logistic and linear models under complex sampling scheme.
The true value β∗1 = 0.2. "LogR" stands for the logistic regression. "LR" stands for the linear
regression. "IPW" stands for inverse probability weighted quantile regression. "SICO (T)"
stands for proposed SICO estimates with T replicate. "CE" stands for proposed CE estimates
using kernel smoothing techniques for logistic regression and one-step optimization for
linear regression.
τ= 0.5 τ= 0.9
Model Method RB (%) SE MSE ×n RB (%) SE MSE ×n
Quantile Model (1) IPW 8.4 0.070 9.9 2.7 0.094 17.7
SICO (T=10) -0.5 0.041 3.4 0.6 0.054 5.8
Quantile Model (2) IPW -18.6 0.147 44.3 -106.0 0.312 251.0
SICO (T=10) -0.8 0.026 1.3 -1.0 0.102 20.7
Table 4.6: The relative biase (RB), standard error (SE) and mean squared error (MSE)
of the estimated coefficient β1,τ for Quantile Model (1) and (2) under complex sampling
scheme. The true β1 is 0.12+ 0.02Qei(τ). In Quantile Model (1), ei ∼ N(0, 1). In Quantile
Model (2), ei ∼ χ21/
p
2. "IPW" stands for inverse probability weighted quantile regression.
"SICO (T)" stands for proposed SICO estimates with T replicate. "CE" stands for proposed
CE estimates using kernel smoothing techniques.
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4.4 Type I error estimates in comparison with SPML
In Section 4.1, we observe that the SPML approach is more efficient than our proposed
methods in Logistic Setting, but involves biases under Interaction and Piecewise Settings.
In this section, we would like to investigate the type I error of proposed SICO estimates in
comparison with SPML for the primary hypothesis H0 : β1 = 0 under the three settings we
consider. We consider with a binary Y , a single pre-selected SNP with MAF of 10% to 50%.
We simulate 100,000 Monte-Carlo samples with 2,000 cases and 2,000 controls. For the
proposed SICO estimates, we consider a bootstrap procedure proposed in Section 3.6 for
testing. Table 4.7 summarizes the Type I errors of the proposed SICO (T=10) and of the
SPML method under the Logistic, Interaction and Piecewise settings and at the α levels of
0.05, 0.01 and 0.001. According to the table, the SICO has the correct Type I errors in all
the settings we consider, while the SPML method has inflated type I error in the Interaction
and the Piecewise Setting due to the deviation from the linear logistic model assumption.
Logistic Interaction Piecewise
Method MAF 0.05 0.01 0.001 0.05 0.01 0.001 0.05 0.01 0.001
SPML 0.1 0.04924 0.01008 0.00119 0.25043 0.10064 0.02311 0.09353 0.02449 0.00351
0.2 0.04969 0.01017 0.00110 0.37414 0.17526 0.04829 0.12961 0.03881 0.00647
0.3 0.04963 0.01038 0.00105 0.42709 0.21057 0.06665 0.15627 0.05126 0.00965
0.4 0.05029 0.01002 0.00126 0.44216 0.22318 0.06905 0.17422 0.05983 0.01117
0.5 0.05087 0.01051 0.00102 0.42486 0.21007 0.06234 0.17610 0.06265 0.01238
SICO 0.1 0.04944 0.01001 0.00095 0.05649 0.01219 0.00113 0.05104 0.01106 0.00119
(T=10) 0.2 0.04945 0.00997 0.00102 0.05585 0.01248 0.00108 0.05187 0.01143 0.00147
0.3 0.04994 0.00973 0.00107 0.05903 0.01286 0.00134 0.05368 0.01123 0.00147
0.4 0.05105 0.00958 0.00098 0.05943 0.01254 0.00132 0.05285 0.01163 0.00164
0.5 0.04897 0.01013 0.00092 0.05912 0.01353 0.00135 0.05193 0.01181 0.00160
Table 4.7: Type I error of SICO estimates in comparison with SPML for a pre-selected SNP.
"SPML" stands for semi-parametric maxmium likelihood based logistic regression. "SICO
(T)" stands for proposed SICO estimates with T replicate.
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4.5 The performance under biased estimated bP(D|X ,Z)
The proposed estimates require a consistently estimation of P(D|X ,Z). In previous sim-
ulation studies, we assumed that the primary disease prevalence P0 is known, and we
estimated P(D|X ,Z) assuming a linear logistic model as follows
P(D = 1|X ,Z) = exp(γ0+ Xγ1+ ZTγ2)/{1+ exp(γ0+ Xγ1+ ZTγ2)}.
In practice, we might encounter two issues. First, the disease prevalence often esti-
mated from cohort studies or literature could be mis-specified. For this problem, we will
demonstrate the performance of proposed estimators when estimated disease prevalencebP0 largely differs from the true value in both GLM and quantile regressions.
Second, the linear logistic model may not be a good approximation of the associa-
tion between the disease status and the covariates (X ,Z). For example, when the dis-
ease prevalence is low, which is one of the main reasons to employ a case-control de-
sign, P(D|X ,Y,Z) = exp(γ0 + Xγ1 + ZTγ2 + Yγ3)/{1 + exp(γ0 + Xγ1 + ZTγ2 + Yγ3)} ≈
exp(γ0+ Xγ1+ZTγ2+ Yγ3). Consequently, the logistic model also holds for P(D = 1|X ,Z)
if Y follows an exponential family distribution. When the disease prevalence is high, how-
ever, this approximation may not work and the estimation using the linear logistic model
may be biased. In the simulation studies in Section 4.1, we have already considered the per-
formance of the proposed estimates under three disease models, Logistic, Interaction and
Piecewise Setting. Here, we further investigate this problem under quantile framework by
demonstrating the performance of SICO and CE estimates when the disease prevalence P0
is high and therefore the logistic model for P(D|X ) is mis-specified.
Table 4.8 and 4.9 show the relative bias, standard error and mean squared error of
the estimated coefficients from 500 Monte-Carlo replicates with various bP0 values used for
estimation. For Table 4.8, we use data from Logistic Model (Model 4.1) and Linear Model
(Model 4.2) in Section 4.1, but re-estimate the parameters based on different estimated
disease prevalence bP0 ranging from P0/2 to 2P0, where P0 =10% is the true prevalence.
For Table 4.9, we use the data from Quantile Model (1) (Model 4.3 with normal error) in
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Logistic Model (SICO (T=10)) Linear Model (CE)bP0 RB (%) SE MSE ×n RB (%) SE MSE ×n
P0/2 -3.5 0.075 11.3 -6.0 0.032 2.4
P0/1.5 -2.0 0.073 10.7 -4.3 0.032 2.1
P0/1.2 -0.7 0.071 10.2 -2.7 0.031 2.0
P0 -0.5 0.074 10.8 -1.1 0.030 1.9
1.2P0 2.1 0.068 9.3 0.6 0.030 1.8
1.5P0 4.0 0.066 8.7 2.9 0.029 1.7
2P0 6.8 0.062 8.0 6.2 0.028 1.8
Table 4.8: The relative bias (RB), standard error (SE) and mean squared error (MSE) of
the estimated coefficient β1 with misspecifed bP0 under Logistic Model and Linear Model.
P0 = 10% is the true disease prevalence.
Section 4.2, and also re-estimate the parameters based on estimated bP0 ranging from P0/2
to 2P0. We find the estimation bias does increase slowly as the prevalence deviates from
the true one, but the differences are small even when doubling P0.
In Table 4.10, we simulate the data according to Quantile Model (2) (Model 4.3 with
χ2 error) in Section 4.2, but the true disease prevalence P0 increases from 5% to 30%.
In all the cases, the relative biases from the SICO estimates are smaller than 4%, which
indicates its robustness against the deviation from the logistic P(D|X ,Z). The CE estimates
are relatively more sensitive to the bias under Quantile Model (2) with higher disease
prevalence.
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τ= 0.5 τ= 0.9bP0 Method RB (%) SE MSE ×n RB (%) SE MSE ×n
P0/2 CE -9.1 0.043 4.0 -7.9 0.059 7.2
SICO (T=10) -8.7 0.043 3.9 -7.5 0.058 6.9
P0/1.5 CE -7.8 0.043 3.9 -6.4 0.059 7.0
SICO (T=10) -7.2 0.043 3.8 -5.9 0.057 6.6
P0/1.2 CE -6.3 0.043 3.8 -4.4 0.058 6.7
SICO (T=10) -5.9 0.042 3.7 -4.2 0.056 6.4
P0 CE -4.7 0.042 3.6 -2.0 0.056 6.3
SICO (T=10) -4.5 0.042 3.6 -2.7 0.056 6.2
1.2P0 CE -3.7 0.042 3.5 -1.1 0.055 6.1
SICO (T=10) -2.9 0.042 3.5 -0.9 0.055 6.0
1.5P0 CE -1.1 0.041 3.4 1.2 0.055 6.0
SICO (T=10) -0.4 0.041 3.4 1.7 0.054 5.7
2P0 CE 3.4 0.040 3.3 5.2 0.052 5.5
SICO (T=10) 3.4 0.040 3.3 5.8 0.052 5.4
Table 4.9: The relative bias (RB), standard error (SE) and mean squared error (MSE) of
the estimated quantile coefficients β1,τ with misspecifed bP0 under Quantile Model (1) at
quantile levels 0.5 and 0.9. P0 = 5% is the true disease prevalence.
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τ= 0.5 τ= 0.9
Prev Method RB (%) SE MSE ×n RB (%) SE MSE ×n
0.05 SICO (T=10) 2.0 0.026 1.3 0.2 0.098 19.3
CE 2.2 0.026 1.4 -0.9 0.100 19.8
0.1 SICO (T=10) -0.1 0.024 1.1 -2.3 0.089 15.9
CE 1.5 0.025 1.2 8.8 0.095 18.4
0.2 SICO (T=10) 0.2 0.021 0.9 -3.6 0.081 13.2
CE 2.6 0.022 1.0 8.5 0.089 16.2
0.3 SICO (T=10) 0.2 0.019 0.7 -1.9 0.079 12.4
CE 3.1 0.020 0.9 12.3 0.086 15.4
Table 4.10: The relative bias (RB), standard error (SE) and mean square error of the
estimated coefficients β1,τ under Quantile Model (2) at quantile levels 0.5 and 0.9. "SICO
(T)" stands for proposed SICO estimates with T replicate. "CE" stands for proposed CE





In this chapter, we apply the proposed new estimating equation based approach to conduct
the secondary analysis in two different contexts, the Risk Assessment of Cerebrovascular
Event study and the New York University Bellevue Asthma Study. In the first example, we
consider the highly prevalent complex disease diabetes as the binary secondary phenotype
using the young onset stroke case-control data. Diabetes is strongly associated with the
young onset stroke, and for the SNPs that are also associated with stroke, the traditional
methods may be largely bias. We demonstrate the performance of our new estimating
equations based approach in comparison with comparable existing methods in the litera-
ture. In addition, we investigated the algorithm problem of SPML approach we encounter
in this real data example. In the second example, we consider the association of TSLP gene
with a continuous secondary phenotype, serum IgE level, using asthma case-control data.
We first consider the mean level associations, and apply IPW, SPML and the proposed CE
estimate for the secondary analysis under the linear regression framework. Second, we
extend the analysis to quantile regression to obtain a more comprehensive picture of the
genetic association with the secondary outcome. We demonstrate the attractive properties
of secondary quantile regression in comparison of mean regression in different SNPs we
analyzed. These examples clearly present the value of the new estimating equation based
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approach in the secondary trait analysis in genetic case-control studies.
5.2 Application to Risk Assessment of Cerebrovascular Events
(RACE) Study
To illustrate the application of these methods, we select two SNPs, rs6712932 and rs1990760,
from the Risk Assessment of Cerebrovascular Events (RACE) Study to estimate their genetic
association with diabetes. RACE is a GWA study available in the dbGaP database that in-
cludes 1,220 young onset stroke cases and 1,273 controls from the Risk Assessment of
Cerebrovascular Events Study in Pakistan [Cornelis et al., 2010]. The SNPs rs6712932
and rs1990760 have been found genome-wide significant in several previous studies with
diabetes [Salonen et al., 2007; Todd et al., 2007]. SNP rs6712932-G is reported to be a
protective factor for type-2 diabetes with OR=0.66 (CI: 0.54 - 0.79) [Salonen et al., 2007]
and SNP rs1990760-G is reported to be protective from type-1 diabetes with OR=0.85 (CI:
0.81 - 0.90) [Todd et al., 2007]. In this section, we evaluate the association between these
two SNPs and diabetes using this case-control dataset. For notation, we let D = {0,1}
denote the primary case-control status of young onset stroke, Y = {0, 1} denote the binary
secondary phenotype of diabetes, X = {0, 1,2} denote the count of minor alleles for each of
the two SNPs, and Z denote a continuous variable, the propensity score [Guo and Fraser,
2010] developed from a set of covariates including age, gender, smoking status, coronary
artery disease, myocardial infarction and the top 10 principle components from population
stratification using EIGENSTRAT [Price et al., 2006a]. The association between secondary
phenotype diabetes Y and each of the pre-selected SNPs X is modeled by the following
model
P(Y = 1) =
exp(β0+ β1X + β2Z)
1+ exp(β0+ β1X + β2Z)
,
where β1 is the coefficient of interest that relates diabetes to the SNP.
Both types of diabetes are known to be risk factors for stroke [Peters et al., 2014;
Sundquist and Li, 2006]. In this dataset, we only have information on whether a subject
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has diabetes without further specification on the type of diabetes. In the primary analysis
of the risk factors for young onset stroke, we estimate the OR of having diabetes is 3.18
(p-value< 0.0001) for the young onset stroke. In addition, both SNPs are associated with
young onset stroke with marginal per-minor-allele OR as 1.14 (p-value=0.024) and 0.87
(p-value=0.015), respectively. After adjusting for diabetes, the associations between these
SNPs and stroke remain significant (rs6712932: OR=1.16; p-value=0.017. rs1990760:
OR=0.84; p-value=0.003). This is a scenario where the commonly-used tradition methods
may provide biased estimation for the association between these two SNPs and diabetes,
and we should apply appropriate approaches for estimation.
We evaluated the association between diabetes and the SNPs using all the methods we
considered in the simulations, including (1) regression using cases only, (2) regression us-
ing controls only, 3) regression using combined case-control sample, (4) regression using
case-control sample adjusting for case-control studies, (5)IPW, (6) SPML, (7) the proposed
SICO estimates and (8) the proposed CE estimates. The prevalence of stroke in adult Pak-
istan population is needed for the estimating equations and the SPML approach, and we
estimated it to be approximately 3.6% by using our best knowledge from the literature
[Pakistan Stroke Society, 2006]. For IPW approach, there is no clear selection probabil-
ity, so we used the disease prevalence to approximate the ratio of selection probabilities
between cases and controls and used bootstrap method to construct bootstrap standard
errors and p-values for inference. For the proposed SICO and CE methods, bootstrap tests
were used to construct the standard error and calculate the p-value.
Table 5.1 presents the results of the association between the SNPs and diabetes using
the eight different approaches. For SNP rs6712932, all of these methods yielded similar
effect estimates suggesting no significant association between rs6712932 and diabetes. We
observe the directions for the genetic association with stroke and diabetes are opposite,
which might also suggest the marker has little or no true association with diabetes in this
general population. When there is no or little association between the tested marker and
the secondary trait, the biases of the traditional methods are small, which is consistent with
the findings in Monsees et al. [2009]. Among the all the theoretical unbiased methods we
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consider, SPML approach is the most efficient, followed by CE estimate and SICO estimate,
and IPW is the least efficient.
For the SNP rs1990760, there is a significant protecting association among controls.
While in the same direct, the association among cases has different value and is not sig-
nificant. Regression on the case-control sample ignoring the sampling scheme or adjusting
for the primary disease produce point estimates (-0.126 and -0.159) that are closer to
the one among cases (-0.112) than that of controls (-0.247). Since cases constitutes a
small percentage of general population, it suggests the estimates from the two methods
may be biased from the true association in general population. The proposed SICO and
IPW detect similar significant protecting associations between SNP rs1990760 and dia-
betes that are closer to the controls (βˆ = −0.227, p-value=0.0374 for SICO; βˆ = −0.228,
p-value=0.0365 for IPW). We expect their estimates are closer to the true value in the
population. CE estimate is more efficient but potential contains some biases (βˆ = −0.142,
p-value=0.0379 ). This is because the estimation process involves kernel smoothing tech-
niques, and it does not work well when there are few observations in the neighborhood of
(X , Z). In this particular example, the covariate Z has heavy tail among cases.
Interestingly, we observe that the SPML method fails to generate an estimate for SNP
rs1990760 in Table 5.1 due to an algorithm problem in their software. To further inves-
tigate the problem of the SPML approach, we apply the method to the top 1000 SNPs
selected from the association analysis with the primary disease (p-value<1.5E-3). The fail-
ure rate of the SPML approach in generating an estimate is presented in figure 5.1. We can
see that when the SNP is strongly associated with the primary disease, which is also the
case that the traditional methods are likely to bias, the SPML approach is highly likely to
fail. For example, among the top 20 SNPs (p-value<1.5E-10) , the failure rate is as high as
40%. This is because when the continuous covariate enters into the algorithm, it is treated
as a high-dimensional nuisance parameter of the likelihood function that has to be profiled
out at each value. When we conduct the same analysis without adjusting for the covariates,
the SPML approach works well.




Est βˆ1 OR S.E. p-value Est βˆ1 OR S.E. p-value
Case-control -0.060 0.94 0.074 0.4166 -0.126 0.88 0.068 0.0648
Case -0.100 0.90 0.092 0.2800 -0.112 0.89 0.088 0.2024
Control -0.125 0.88 0.132 0.3441 -0.247 0.78 0.118 0.0368
Stratified case-control -0.108 0.90 0.076 0.1530 -0.159 0.85 0.071 0.0246
IPW -0.113 0.89 0.134 0.4009 -0.228 0.80 0.109 0.0365
SPML -0.099 0.91 0.075 0.1888 NA NA NA NA
SICO (T=10) -0.098 0.91 0.127 0.4381 -0.227 0.80 0.109 0.0374
CE -0.106 0.90 0.089 0.2336 -0.142 0.86 0.068 0.0379
Table 5.1: The association between two pre-selected SNPs (rs6712932 and rs1990760) and
diabetes in a young onset stroke case-control sample. "Case-control" stands for unadjusted
logistic regression using both case and control samples. "Case" stands for unadjusted lo-
gistic regression using case sample only. "Control" stands for unadjusted logistic regression
using control sample only. "Stratified" stands for logistic regression using both case and
control samples adjusting for primary disease status. "IPW" stands for inverse probabil-
ity weighted logistic regression. "SPML" stands for semi-parametric maxmium likelihood
based logistic regression. "SICO (T)" stands for proposed SICO estimates with T replicate.
"CE" stands for proposed CE estimates using kernel smoothing techniques.
the secondary trait Y , all methods provide valid estimates. When the tested marker X is po-
tentially associated with the secondary trait Y , the traditional methods may contain biases.
Among the theoretical justified unbiased approaches, IPW and SICO estimates provide ro-
bust and similar estimation for the association between the tested marker and secondary
trait. SPML is more efficient, but is subject to biases from violation of model assumptions
and algorithm problems. CE estimate requires kernel smoothing approximations in logistic
regression and might be biased if the sample is unbalanced in cases and controls. In the
next example, we consider CE estimate for linear regression, which does not need the ker-
nel smoothness for its estimation. It provides similar point estimate but is more efficient
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than IPW approach, which indicates its value in analyzing the secondary trait.
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Figure 5.1: The failure rate of SPML method
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5.3 Application to New York University Bellevue Asthma
Study
In this section, we apply the proposed methods to study the association between the Thymic
stromal lymphopoietin (TSLP) gene and serum IgE levels from the New York University
Bellevue Asthma Registry [Liu et al., 2011]. The study consisted of 387 asthmatics and
212 healthy controls, and measured 10 tag SNPs in the TSLP gene. IgE is a class of anti-
body that is elevated in various allergic diseases. Understanding the genetic basis of IgE
paves to way to recognize the mechanism of TSLP in affecting asthma and other allergic
diseases. Therefore, the purpose of the secondary analysis is to identify the TSLP SNPs that
are associated with elevated serum IgE level. Since log serum IgE level is approximately
normally distributed among cases and controls, we first consider least square regression
and compare the results with existing novel methods including IPW and SPML. Second, as
elevated IgE level instead of mean IgE level plays an essential role in allergic diseases, we
are also interested to apply the quantile regression to further investigate the genetic asso-
ciation with upper quaniles of the IgE. We illustrate the two types of regressions separately.
5.3.1 Mean regression
We denote X as the minor allele count for each of the 10 TSLP SNPs, Z as a continuous vari-
able derived as the first principal component score from 213 ancestry informative markers
to adjust for population stratification, and Y as the log serum IgE level. Then the least
square model we consider is as follows
Y = β0+ β1X + β2Z .
Three approaches are used to estimate the coefficient β1: the IPW approach, SPML
approach, and proposed CE approach. We calculate the overall asthma prevalence as 10.1%
based on 6 birth cohort studies, and this information is used to approximate selection
probability in IPW, and estimate P(D|X ,Y, Z) in SPML and P(D|X ) in CE. The standard
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errors and p-values in proposed CE estimates were calculated using bootstrap, i.e. we
bootstrap cases and controls separately, and re-apply the entire estimating procedure to
the bootstrap case-control sample.
The resulting estimated coefficients are summarized in Table 5.2. The point estimates
of the CE coefficients are very similar to IPW, while the estimates from SPML are largely dif-
ferent in many SNPs. We know from simulations in Chapter 4 that IPW is robust and SPML
is efficient but potentially biased with mis-specified P(D|X ,Y, Z). To understand if SPML is
potentially biased, we further tested the X − Y interactions in P(D|X ,Y, Z) to understand
the underlying models, and some of the interactive effects are significant (SNPs rs2289278
and rs10035870). Therefore, we believe that the SPML approach is substantively biased
due to the violation of the model assumptions, and the proposed CE estimates as well as
IPW provides relative unbiased estimations. The Table 5.2 also shows that the proposed
CE estimates are more efficient than IPW approach in analyzing the genetic associations.
In details, IPW only detects one significant SNP rs10035870 at α-level 0.05 , while CE
identifies three (rs11466741, rs11466743 and rs10035870). In summary, the proposed
new estimating equation based approach (CE estimator in particular) combines the advan-
tages of IPW and SPML estimators that its is robust and fairly efficient in estimating the
marker-secondary trait associations. Therefore, it is useful in real data analysis to discover
potential SNPs.
5.3.2 Quantile regression
In this section, we consider the quantile regression for the association between TSLP gene
and the upper quantiles of the log serum IgE level. We are particularly interested in dis-
covering the SNPs that are associated with elevated IgE levels, and quantile regression is
able to present a comprehensive picture on the where the effects of the SNPs exist on the
distribution of serum IgE levels. The quantile model we consider is as follows:
QY (τ) = β0,τ+ β1,τX + β2,τZ ,
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SNP Method Est. S.E. p-value SNP Method Est. S.E. p-value
rs2289276 IPW 0.09 0.14 0.500 rs2289278 IPW -0.29 0.22 0.193
SPML 0.06 0.10 0.569 SPML 0.05 0.16 0.764
CE 0.10 0.08 0.252 CE -0.29 0.16 0.077
rs1898671 IPW -0.12 0.17 0.505 rs11241090 IPW 0.14 0.33 0.658
SPML -0.12 0.10 0.262 SPML 0.20 0.22 0.377
CE -0.11 0.13 0.380 CE 0.14 0.24 0.554
rs11466741 IPW 0.20 0.12 0.112 rs10035870 IPW 0.63 0.28 0.024
SPML 0.03 0.09 0.721 SPML 0.03 0.21 0.904
CE 0.20 0.09 0.032 CE 0.63 0.22 0.004
rs11466743 IPW -0.61 0.34 0.073 rs11466749 IPW 0.07 0.24 0.779
SPML -0.25 0.29 0.382 SPML 0.14 0.15 0.343
CE -0.61 0.29 0.034 CE 0.07 0.16 0.678
rs2289277 IPW 0.13 0.12 0.282 rs11466750 IPW -0.05 0.16 0.748
SPML 0.03 0.09 0.739 SPML 0.08 0.12 0.484
CE 0.13 0.09 0.165 CE -0.05 0.13 0.671
Table 5.2: Estimated mean allelic effects on log serum IgE level in linear regression. "IPW"
stands for inverse probability weighted least squared regression. "SPML" stands for semi-
parametric maximum likelihood least squared regression. "CE" stands for proposed CE
estimates using one-step optimization
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where the X is the minor allele count for each of the 10 TSLP SNPs, Z is a continuous vari-
able derived as the first principal component score from 213 ancestry informative markers
to adjust for population stratification, and Y is the log serum IgE level.
To evaluate effects of the TSLP gene variants on different levels of IgE, we estimated the
model at quantile levels of 0.15, 0.25, 0.5, 0.75 and 0.85, respectively. Three approaches
were used to estimated the quantile coefficients: the IPW approach and the proposed SICO
and CE methods. SPML approach is not considered for quantile regression as it is based
on likelihood function and can not be applied to non-parametric regressions. Similar to
the simulation studies, we use a Gaussian kernel and select the bandwidth using 5-fold
cross-validation for the CE estimates. The resulting estimated quantile coefficients are
summarized in Table 5.3. All the p-values in Table 5.3 were calculated using bootstrap, i.e.
we bootstrap cases and controls separately, and re-apply the entire estimating procedure
to the bootstrap case-control sample. The estimated quantile coefficients from the three
approaches are comparable. However, due to the small sample size in this particular exam-
ple, the bootstrap standard errors of the CE estimates and IPW estimates are much bigger
than the ones from SICO estimates. Consequently, the SICO estimates are more powerful
to detect the quantile associations with small sample sizes.
From the mean coefficients output for CE estimates in Table 5.2, we observed that SNPs
rs11466741, rs11466743 and rs10035870 had significant associations with mean serum
IgE level, with p-values of 0.032, 0.034 and 0.004, respectively. The results from quantile
regressions also indicated significant association with these SNPs, and these associations
remain significant even after a conservative Bonferroni correction for estimating different
quantile levels and the number of SNPs. Moreover, quantile analysis presented a more com-
prehensive picture on the effects of the SNPs and suggested that the SNPs have different
impact on the distribution of serum IgE level. For example, having one or two A allele of
SNP rs11466743 decreases the mean of IgE value by 0.61. Based on the quantile analysis,
however, this SNP has no effect on the lower quantiles (0.15th and 0.25-th quantiles) of
IgE value, but significantly decreases the median and upper (0.75th and 0.85th) quantiles
of IgE by 0.6, 1.2 and 1.1, respectively. In addition, elevated serum IgE level indicates
69
CHAPTER 5. APPLICATIONS
hypersentitive allergic effect and thus it is important to know the TSLP effects on the upper
quantile of serum IgE level. Specifically, the propose method showed that SNPs rs2289276,
rs2289278, rs2289277 and rs11466750 have significant association with 75th quantile of
log serum IgE level; however, the mean regression did not indicate significant association,
illustrating the potential for the new approach to discover new associations.
Moreover, to see how genetic variants impact the distribution of serum IgE level, we
estimate the quantile coefficients on a fine grid of quantile levels. In Figures 5.2(a) and
5.2(b), we plot the estimated conditional distribution functions with different genotypes
at SNPs rs10035870 and rs11466743, respectively. Specifically, the solid curve in Figure
5.2(a) is the estimated quantile function for the patients whose genotype at rs10035870 is
AA, and the dashed line is that of those whose genotype is AG/GG at rs10035870. In Figure
5.2(b), the solid curve is the estimated quantile function with genotype GG at rs11466743,
and the dashed line is that of genotype AG/AA.
Both SNPs were found to have significant impact on the distribution of serum IgE level.
Based on Figure 5.2(a), rs10035870 has strong positive effect on the entire distribution
of serum IgE level, and thus subjects with the mutation allele of rs10035870 tend to have
higher serum IgE level in general. In contrast, SNP rs11466743 only has strong impact on
the median and upper quantiles, but makes little difference at the lower quantiles of serum
IgE level. As indicated in Figure 5.2(b), the subjects with genotype AG/AA in rs11466743
are less likely to have a very high serum IgE level compared to those with genotype GG,
however, they also have equal chance to have low IgE serum level. For example, for the
subjects with rs11466743 genotype AG/AA, the probability of hypersensitive allergic ef-
fects (Y > 5) is nearly zero. However, for the subjects with genotype GG, this probability
is approximately 30%. However, the probabilities of log IgE serum level (Y < 3) are 25%
for all the genotypes.
In the original case-control asthma study, we found that the SNP rs1898671 was associ-
ated with the asthma disease risk. When examining the genetic association with the serum
IgE levels, we identified different associated SNPs. Asthma is an allergic immune disorder
that is usually diagnosed based on the pattern of symptoms, response to therapy over time
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Figure 5.2: The estimated distribution functions of log serum IgE level associated with SNP
rs10035870 and rs11466743.
and spirometry. With allergic effects, serum IgE levels may be normal or sub-normal. In
addition, the elevation of serum IgE levels may be caused by different allergic diseases than
asthma. Therefore, it is nature to find out the analysis of the secondary outcome serum IgE
levels discovers different SNPs from the primary analyses.
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τ= 0.15 τ= 0.25 τ= 0.5 τ= 0.75 τ= 0.85
SNP Method Est. P-value Est. P-value Est. P-value Est. P-value Est. P-value
rs2289276 IPW -0.1 5.0E-01 -0.1 6.9E-01 0.4 1.1E-02 0.5 6.1E-02 0.1 6.9E-01
SICO -0.1 6.4E-02 0.0 9.7E-01 0.4 3.8E-07 0.3 8.7E-04 0.0 7.5E-01
CE -0.1 3.4E-01 0.0 9.2E-01 0.4 2.6E-02 0.3 1.1E-01 -0.1 7.4E-01
rs1898671 IPW -0.1 5.4E-01 -0.3 9.5E-02 -0.3 2.1E-01 0.3 3.9E-01 -0.1 7.1E-01
SICO -0.2 9.2E-03 -0.2 3.9E-03 -0.2 8.8E-03 0.2 6.7E-02 0.0 9.8E-01
CE -0.1 5.1E-01 -0.2 2.6E-01 -0.2 4.8E-01 0.2 6.0E-01 0.2 5.9E-01
rs11466741 IPW -0.1 6.5E-01 0.1 5.1E-01 0.5 3.6E-03 0.4 1.5E-02 0.2 3.9E-01
SICO 0.0 4.1E-01 0.1 1.7E-01 0.4 8.4E-08 0.3 3.5E-04 0.1 3.6E-01
CE -0.1 6.8E-01 0.1 4.7E-01 0.4 1.1E-02 0.4 4.3E-03 0.0 9.6E-01
rs11466743 IPW 0.4 6.7E-01 0.0 9.4E-01 -0.5 8.2E-02 -1.1 3.6E-02 -1.1 1.4E-02
SICO 0.4 1.6E-01 0.0 9.7E-01 -0.6 1.2E-03 -1.2 1.2E-11 -1.1 5.4E-08
CE 0.4 6.6E-01 -0.1 8.9E-01 -0.6 7.4E-02 -1.2 3.5E-03 -1.2 5.0E-04
rs2289277 IPW -0.1 5.5E-01 -0.1 7.1E-01 0.3 2.2E-01 0.3 1.3E-01 0.2 4.6E-01
SICO -0.1 7.1E-02 0.0 5.5E-01 0.3 1.7E-04 0.3 5.7E-03 0.1 3.7E-01
CE -0.1 6.5E-01 0.0 9.2E-01 0.3 2.0E-01 0.3 5.2E-02 0.0 9.1E-01
rs2289278 IPW -0.1 7.1E-01 -0.3 2.7E-01 -0.1 7.6E-01 -0.5 2.3E-01 -0.5 3.1E-01
SICO -0.1 1.6E-01 -0.3 2.1E-03 -0.1 2.2E-01 -0.5 3.4E-04 -0.3 7.1E-02
CE -0.1 6.6E-01 -0.3 2.5E-01 -0.2 5.1E-01 -0.5 1.6E-01 0.0 9.7E-01
rs11241090 IPW 0.4 4.7E-01 0.4 3.4E-01 -0.3 5.9E-01 -0.1 9.4E-01 0.4 6.1E-01
SICO 0.4 3.2E-02 0.3 2.3E-02 -0.3 1.6E-01 0.0 9.3E-01 0.3 2.8E-01
CE 0.4 3.4E-01 0.4 3.6E-01 -0.3 5.4E-01 -0.2 7.6E-01 0.5 4.8E-01
rs10035870 IPW 0.7 1.1E-01 0.5 2.3E-01 0.8 2.6E-01 0.8 2.0E-02 0.4 3.1E-01
SICO 0.8 1.1E-09 0.6 9.0E-07 0.9 5.4E-07 0.8 3.1E-04 0.4 3.7E-02
CE 0.7 4.2E-02 0.5 1.1E-01 0.7 2.9E-01 0.7 6.8E-03 0.3 4.5E-01
rs11466749 IPW -0.2 3.8E-01 -0.2 5.3E-01 0.1 8.8E-01 0.2 6.9E-01 0.3 5.6E-01
SICO -0.2 2.2E-02 -0.2 6.8E-02 0.0 7.1E-01 0.1 2.7E-01 0.3 7.9E-03
CE -0.2 3.3E-01 -0.2 4.2E-01 0.0 9.2E-01 0.1 8.3E-01 0.4 2.6E-01
rs11466750 IPW -0.1 5.0E-01 -0.1 6.6E-01 -0.3 8.2E-02 -0.2 5.1E-01 -0.1 8.7E-01
SICO -0.2 3.3E-02 -0.1 5.5E-02 -0.3 2.1E-04 -0.3 4.2E-03 0.1 4.2E-01
CE -0.1 5.0E-01 0.0 8.4E-01 -0.3 1.1E-01 -0.3 3.4E-01 0.2 5.9E-01
Table 5.3: The estimated allelic effects on log serum IgE level in quantile regression at
quantile levels of 0.15, 0.25, 0.5, 0.75, and 0.85. "IPW" stands for inverse probability
weighted quantile regression. "SICO" stands for proposed SICO estimates with 10 replicate.
"CE" stands for proposed CE estimates using kernel smoothing techniques.
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Conclusions and future work
In this paper, we propose a general framework to estimate the genetic association with
secondary phenotype in case-control studies. In this chapter, we discuss and summarize
the advantages as well as some limitations of the proposed approach. In the first section,
some important conclusions are listed. We then point out a few possible future directions
on this topic in the second section.
6.1 Conclusions
We propose a new estimating equation based approach to estimate the association be-
tween genetic variants and secondary phenotype in the case-control designs. It combines
observed and counter-factual outcomes to constitute unbiased estimating equations. Com-
pared with the existing unbiased approaches, including the IPW and SPML, it has the
following attractive features.
First, it can accommodate various types of phenotypes (e.g., binary, continuous and or-
dinal), SNPs models (additive, dominant or recessive), and regressions (e.g., least square
regression, GLM, quantile regression). Likelihood function based approaches, such as
SPML approach, lack of the flexibility and diversity.
Second, it can easily accommodate covariates, including population substructure, an
important confounding in genetic studies. When we encounter a large number of covari-
ates, it is easy to conduct variable selection using cross-validation or introduce penalty
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functions, like Lasso, Elastic Net, and SCAD.
Third, it relaxes the common conditions on the disease prevalence models. Except for
the IPW approach, most secondary trait analyses using the entire case-control sample as-
sume logistic models of P(D|X ,Y,Z). Our proposed estimating equations approach is more
general, and only assumes that the disease probability follows a logistic model with just
(X ,Z); it is not affected by the underlying distribution of Y . In section 4.1, while most ex-
isting methods are biased when P(D|X ,Y, Z) doesn’t follow the logistic model in the Piece-
wise Setting, our proposed estimating equations are robust to the model mis-specification.
Certainly, there is a price to be paid for the flexibility of the model assumptions. When
the underlying P(D|X ,Y,Z) satisfies the model assumptions in the SPML approach, the
SPML method shows greater efficiency than our proposed approach. As expected, there
is a trade-off between the robustness and efficiency of the models, and depending on the
underlying true model a different method may be optimal.
Fourth, the proposed approach is not sensitive to sampling schemes. Although the IPW
approach is a simple and flexible method that works for any models, it requires knowing the
additional information on sampling probabilities. As shown in the simulations in Section
4.3, the resulting estimates may not be efficient under some types of sampling schemes.
For example, under the complex sampling schemes, where the some sampling variables are
unrelated to the disease status, the IPW estimates are very inefficient.
Fifth, it requires little external information to be known. In secondary trait analyses,
it is hard to obtain unbiased estimation without any external information. The proposed
method only requires the disease prevalence P0 to be specified. In contrast, the IPW ap-
proach needs the selection probabilities, which is often hard to obtain when the case-
control sample is not nested within a larger cohort study. The bias correction approach by
[Wang and Shete, 2011] also needs the prevalence of the secondary phenotype in addition
to P0. In principle, the SPML approach might be able to estimate β1 without external in-
formation on disease prevalence, but the resulting inference is unstable Li and Gail [2012]
and their publicly available software at http://www.bios.unc.edu/ lin/softward/SPREG/
requires knowing P0. Thus, no unbiased approaches are able to perform without external
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information of P0 or selection probability. When mis-specified, theses methods are subject
to biases. However, simulations showed the new estimating equations are fairly robust to
such mis-specification.
Finally, it is computationally simple and straightforward. The estimation can be achieved
by weighted regressions. Hence the computation does not require special software.
In summary, the construction of the estimating equations is straightforward and compu-
tationally efficient by simulating pseudo observations and evaluating the expected counter-
factual estimating function. It provides robust and fairly efficient unbiased estimation for
the variant-secondary phenotype association. It has appropriate type I error rate and is
robust to disease prevalence mis-specification. It can be extended to multiple study de-
signs and can be applied to multiple regressions, including regressions with no parametric
likelihood function, such as quantile regression.
6.2 Future extension
We would like to extend the proposed methods to accommodate a wide range of case-
control studies that are biased in secondary analysis. For example, we consider to joint
analyze multiple case-control studies at the same time to improve power. We also consider
the nested/matched case-control design that aims at improving the efficiency of traditional
case-control design. Finally, we consider expanding the secondary analysis from GWAS to
sequencing studies that focus on the rare variants. In this section, we will explain the issues
we might encounter in these directions, and our preliminary ideas of secondary analysis
for the further study.
6.2.1 Secondary analysis in multiple genetic case-control studies
One direction to expand the new estimating equations is to joint analyze of the same
secondary trait from multiple case-control studies. As most of the case-control studies are
powered for the primary analysis, we might have difficulties to detect the important SNPs
for the secondary traits using one case-control sample. Meanwhile, a lot of secondary
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traits, such as height, weight, blood pressure and common diseases, are widely asked in
the case-control studies. It is natural for the researchers to consider using the data from
multiple case-control studies to investigate the associations between the genetic markers
and the same secondary trait of interest. In the example from the introduction [Lettre
et al., 2008], researchers analyzed the secondary trait height using six GWAS focusing on
diabetes, cardiovascular diseases and cancers.
When we consider joint analysis of multiple case-control studies, there are a number
of issues we need to be aware of. First, different GWAS might use different genotyping
platforms, and their SNPs may not overlap each other. Therefore, imputation of the ’hidden’
variants is needed to combine the studies. Imputation is the process of predicting a set of
genotypes that are not directly assayed in a sample of individuals. Imputation methods can
infer the alleles of ’hidden’ variants and use those inferences to test the hidden variants for
association. As imputed SNPs can lead to false positives if they are poorly performed,
or even well performed, the major discovery based on imputed SNPs should be verified,
probably by conducting new studies.
Second, by combining the multiple case-control studies, researchers might accidentally
mix the subjects from different subgroups. If genotype frequencies differ between these
subgroups and sampling favors certain subgroups over others, the sample estimate may be
biased. Even there is no bias, variance of the estimate can be affected, and can affect the
validity of the association test results. Therefore, the adjustment for population stratifica-
tion is particularly important in this scenario when we combine multiple samples to correct
the bias and variance. There are a number of approaches to adjust for population stratifica-
tion, including genomic control [Devlin and Roeder, 1999], STRUCTURE [Pritchard et al.,
2000], Eigenstrat [Price et al., 2006b] and EMMAX [Kang et al., 2010], and among them
Eigenstrat is the most popular approach nowadays in the literature.
After dealing with these issues, one could expand the estimating equations to incorpo-
rate multiple diseases, and conduct the secondary analysis in multiple genetic case-control
studies. For the case-control studies when no overlap in participants, we could simply write
the new estimating equations conditional on the primary disease status separately for each
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study, and take the summation their equations. Therefore, for SICO approach, one can
simulate the pseudo observations y˜i and estimate bP(di|x i,zi) for each sample and conduct
the weighted regressions on the combined multiple original samples and counter-factual
pseudo samples. For CE approach, one can calculate the conditional expectation of the
S(x i, y˜i,zi,β) over y˜i and estimate bP(di|x i,zi) separately for each sample, and conduct
weighted regressions using combined multiple samples by taking the weights from each
individual studies. For multiple case-control studies have overlapped observations, and the
details of the joint analysis, we refer to future research to handle them.
6.2.2 Secondary analysis in nested/matched case-control designs
Another direction of extending the estimating equations is to adapt more complex de-
signs. A lot of GWAS use nested/matched case-control designs to improve the efficiency. A
nested/matched case-control study is a special type of a case-control study in which only
a subset of controls from the cohort are compared to the cases. Unlike in traditional case-
cohort study that cases are compared to a random subset of controls, in a nested/matched
case-control study, some number of controls are selected for each case from that case’s
matched risk set. By matching on factors such as age and selecting controls from relevant
risk sets, the nested case control model is generally more efficient than a case-cohort design
with the same number of selected controls.
To conduct the secondary analysis for a nested case-control sample, one must take into
account the way in which controls are sampled from the cohort. It is common that re-
searchers treat the cases and selected controls as the original cohort and performing a
logistic regression. This can result in biased estimates as the controls are not a representa-
tive sample of the general population. We could possibly expand our proposed approach to
account for the missing covariates among those who are not selected into the study from
the population. This would improve the estimation of bP(di|x i,zi), and results in an unbi-
ased estimates for the general population. Further research needs to be carried out in this
direction for the nested/matched case-control studies.
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6.2.3 Secondary analysis in sequencing studies
The availability of high-throughput sequencing enables rapid sequencing of large stretches
of DNA base pairs spanning entire genomes, and produces new statistical questions to
analyze the association between the secondary trait and rare variants. While the proposed
approaches provide a general framework for case-control studies that are not limited to
GWAS, they could not be simply applied sequencing studies. One major reason is that the
rare variants have very low frequency (MAF< 1%), so there are few occurrences of the
variants in dataset of reasonable sample size. Second, the rare variants are numerous that
over 95% of variants in a region have MAF< 1%, and this increased penalty for multiple
testing. Finally, the effect sizes of the rare variants are not expected to be very large with
expected odds ratio roughly between 4 − 5. As a result, standard association tests and
regressions used in GWAS have very low power to detect the rare variants.
Therefore, when conducing the secondary analysis for sequencing studies, we need first
consider the grouping strategies to handle the rare variants and then apply the proposed
approaches to the treated genetic information for estimation. For example, we could in-
corporate region-based analysis, such as burden tests and sequence kernel association test
[Wu et al., 2011], to aggregate the rare variants within a region, and then apply our esti-
mating equations to the aggregated data to detect the effects in regions. We refer to future
research for handling the sequencing data.
In summary, while proposed for GWA case-control studies, the new estimating equation
based approach can be extended in a number of directions to accommodate the secondary
analysis for many types of genetic studies. Further study is needed to realize these ideas.
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